Document And Entity Information
Document And Entity Information - shares | 9 Months Ended | |
Sep. 30, 2018 | Nov. 02, 2018 | |
Document And Entity Information [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Sep. 30, 2018 | |
Document Fiscal Year Focus | 2,018 | |
Document Fiscal Period Focus | Q3 | |
Entity Registrant Name | Sequential Brands Group, Inc. | |
Entity Central Index Key | 1,648,428 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Accelerated Filer | |
Trading Symbol | sqbg | |
Entity Common Stock, Shares Outstanding | 64,285,289 |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Current Assets: | ||
Cash | $ 12,052 | $ 18,902 |
Restricted cash | 2,027 | 1,531 |
Accounts receivable, net | 63,531 | 60,102 |
Prepaid expenses and other current assets | 11,927 | 8,635 |
Total current assets | 89,537 | 89,170 |
Property and equipment, net | 9,430 | 7,035 |
Intangible assets, net | 965,360 | 995,170 |
Other assets | 10,902 | 5,836 |
Total assets | 1,075,229 | 1,097,211 |
Current Liabilities: | ||
Accounts payable and accrued expenses | 15,179 | 19,126 |
Current portion of long-term debt | 28,300 | 28,300 |
Current portion of deferred revenue | 11,143 | 8,102 |
Total current liabilities | 54,622 | 55,528 |
Long-term debt, net of current portion | 588,226 | 602,297 |
Long-term deferred revenue, net of current portion | 9,130 | 11,845 |
Deferred income taxes | 61,417 | 67,799 |
Other long-term liabilities | 13,334 | 6,204 |
Total liabilities | 726,729 | 743,673 |
Commitments and Contingencies | ||
Equity: | ||
Preferred stock Series A, $0.01 par value; 10,000,000 shares authorized; none issued and outstanding at September 30, 2018 and December 31, 2017 | ||
Common stock, $0.01 par value; 150,000,000 shares authorized; 65,934,552 and 63,652,721 shares issued at September 30, 2018 and December 31, 2017, respectively, and 64,277,335 and 63,227,727 shares outstanding at September 30, 2018 and December 31, 2017, respectively | 656 | 635 |
Additional paid-in capital | 513,439 | 508,444 |
Accumulated other comprehensive (loss) income | (67) | 80 |
Accumulated deficit | (232,531) | (225,369) |
Treasury stock, at cost; 1,657,217 and 424,994 shares at September 30, 2018 and December 31, 2017, respectively | (4,217) | (1,799) |
Total Sequential Brands Group, Inc. and Subsidiaries stockholders’ equity | 277,280 | 281,991 |
Noncontrolling interests | 71,220 | 71,547 |
Total equity | 348,500 | 353,538 |
Total liabilities and equity | $ 1,075,229 | $ 1,097,211 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Sep. 30, 2018 | Dec. 31, 2017 |
Statement Of Financial Position [Abstract] | ||
Preferred stock Series A, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock Series A, shares authorized | 10,000,000 | 10,000,000 |
Preferred stock Series A, shares issued | 0 | 0 |
Preferred stock Series A, shares outstanding | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 150,000,000 | 150,000,000 |
Common stock, shares issued | 65,934,552 | 63,652,721 |
Common stock, shares outstanding | 64,277,335 | 63,227,727 |
Treasury stock, shares | 1,657,217 | 424,994 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Income Statement [Abstract] | ||||
Net revenue | $ 40,771 | $ 39,025 | $ 121,082 | $ 120,569 |
Operating expenses | 23,515 | 16,071 | 60,014 | 57,379 |
Impairment charges | 17,899 | 36,505 | 17,899 | 36,505 |
Loss on sale of assets | 7,117 | |||
(Loss) income from operations | (643) | (13,551) | 36,052 | 26,685 |
Other (income) expense | (31) | (214) | (135) | 1,553 |
Interest expense, net | 15,635 | 15,237 | 46,674 | 44,600 |
Loss before income taxes | (16,247) | (28,574) | (10,487) | (19,468) |
Benefit from income taxes | (8,213) | (3,842) | (6,838) | (142) |
Net loss | (8,034) | (24,732) | (3,649) | (19,326) |
Net (income) loss attributable to noncontrolling interests | (1,581) | 552 | (4,643) | (3,504) |
Net loss attributable to Sequential Brands Group, Inc. and Subsidiaries | $ (9,615) | $ (24,180) | $ (8,292) | $ (22,830) |
Loss per share attributable to Sequential Brands Group, Inc. and Subsidiaries: | ||||
Basic and diluted (in dollars per share) | $ (0.15) | $ (0.38) | $ (0.13) | $ (0.36) |
Weighted-average common shares outstanding: | ||||
Basic and diluted (in shares) | 63,911,481 | 62,998,944 | 63,578,121 | 62,796,716 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY - USD ($) | Total Sequential Brands Group, Inc. and Subsidiaries Stockholders' Equity | Common Stock [Member] | Additional Paid-In Capital [Member] | Accumulated Other Comprehensive Loss [Member] | Accumulated Deficit [Member] | Treasury Stock [Member] | Noncontrolling Interest [Member] | Total |
Treasury stock | $ (1,799,000) | $ (1,799,000) | ||||||
Treasury stock, shares | (424,994) | (424,994) | ||||||
Balance at Dec. 31, 2017 | $ 281,991,000 | $ 635,000 | $ 508,444,000 | $ 80,000 | $ (225,369,000) | $ 71,547,000 | $ 353,538,000 | |
Balance (in shares) at Dec. 31, 2017 | 63,652,721 | |||||||
Stock-based compensation | 3,516,000 | $ 13,000 | 3,503,000 | 3,516,000 | ||||
Stock-based compensation (in shares) | 1,438,345 | |||||||
Shares issued under stock incentive plan | 1,500,000 | $ 8,000 | 1,492,000 | 1,500,000 | ||||
Shares issued under stock incentive plan (in shares) | 843,486 | |||||||
Unrealized gain on interest rate cap | 130,000 | 130,000 | 130,000 | |||||
Repurchase of common stock | (2,418,000) | $ (2,418,000) | (2,418,000) | |||||
Repurchase of common stock (in shares) | (1,232,223) | |||||||
Noncontrolling interest distribution | (5,325,000) | (5,325,000) | ||||||
Net income attributable to noncontrolling interests | 4,643,000 | 4,643,000 | ||||||
Net income attributable to common stockholders | (8,292,000) | (8,292,000) | (8,292,000) | |||||
Unrealized loss on available-for-sale securities | (277,000) | (277,000) | (277,000) | |||||
Balance at Sep. 30, 2018 | 277,280,000 | $ 656,000 | $ 513,439,000 | $ (67,000) | (232,531,000) | 71,220,000 | 348,500,000 | |
Balance (in shares) at Sep. 30, 2018 | 65,934,552 | |||||||
Cumulative effect of revenue recognition accounting change | $ 1,130,000 | $ 1,130,000 | $ 355,000 | 1,485,000 | ||||
Treasury stock | $ (4,217,000) | $ (4,217,000) | ||||||
Treasury stock, shares | (1,657,217) | (1,657,217) |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) | 9 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Cash Flows From Operating Activities | ||
Net income (loss) | $ (3,649,000) | $ (19,326,000) |
Adjustments to reconcile net (loss) income to net cash provided by operating activities: | ||
Provision for bad debts | 30,000 | 381,000 |
Depreciation and amortization | 2,332,000 | 3,544,000 |
Stock-based compensation | 3,516,000 | 5,342,000 |
Amortization of deferred financing costs | 3,145,000 | 2,918,000 |
Loss on debt extinguishment | 148,000 | |
Impairment of trademarks | 17,899,000 | 36,505,000 |
Income from equity method investment | (31,000) | (22,000) |
Loss on disposal of property and equipment | 2,000 | |
Realized loss on sale of available-for-sale securities | 1,916,000 | |
Loss on sale of assets | 7,117,000 | |
Deferred income taxes | (6,845,000) | (447,000) |
Changes in operating assets and liabilities: | ||
Accounts receivable | 2,876,000 | 2,182,000 |
Prepaid expenses and other assets | (8,474,000) | (3,055,000) |
Accounts payable and accrued expenses | (2,548,000) | (4,552,000) |
Deferred revenue | (4,061,000) | (7,361,000) |
Other liabilities | 8,655,000 | 1,233,000 |
Cash Provided By Operating Activities | 20,110,000 | 19,260,000 |
Cash Flows From Investing Activities | ||
Investments in intangible assets, including registration and renewal costs | (210,000) | (280,000) |
Proceeds from sale of available-for-sale securities | 5,757,000 | |
Purchases of property and equipment | (4,053,000) | (1,183,000) |
Proceeds from sale of property and equipment | 2,000 | |
Proceeds from sale of trademarks | 4,356,000 | |
Cash Provided By Investing Activities | 93,000 | 4,296,000 |
Cash Flows From Financing Activities | ||
Proceeds from long-term debt | 107,607,000 | |
Payment of long-term debt | (110,381,000) | (21,225,000) |
Stock registration costs | (20,000) | |
Guaranteed payments in connection with acquisitions | (1,450,000) | (1,950,000) |
Deferred financing costs | (14,590,000) | |
Repurchases of common stock | (2,418,000) | (1,146,000) |
Noncontrolling interest distributions | (5,325,000) | (5,827,000) |
Cash Used In Financing Activities | (26,557,000) | (30,168,000) |
Net Decrease In Cash and Restricted Cash | (6,354,000) | (6,612,000) |
Cash and Restricted Cash - Beginning of period | 20,433,000 | 20,654,000 |
Cash and Restricted Cash - End of period | 14,079,000 | 14,042,000 |
Supplemental Disclosures Of Cash Flow Information | ||
Cash paid for: Interest | 44,173,000 | 41,697,000 |
Cash paid for: Taxes | 74,000 | 90,000 |
Non-cash Investing And Financing Activities | ||
Accrued purchases of property and equipment at period end | 26,000 | 189,000 |
Unrealized loss on available-for-sale securities during the period | 277,000 | |
Unrealized gain (loss) on interest rate cap, net during the period | $ 130,000 | (362,000) |
Receivable for sale of trademark rights | $ 500,000 |
Organization and Nature of Oper
Organization and Nature of Operations | 9 Months Ended |
Sep. 30, 2018 | |
Organization and Nature of Operations [Abstract] | |
Organization and Nature of Operations |  1. Organization and Nature of Operations Overview Sequential Brands Group, Inc. (the “Company”) owns a portfolio of consumer brands in the fashion, active and home categories. The Company aims to maximize the strategic value of its brands by promoting, marketing and licensing its global brands through various distribution channels, including to retailers, wholesalers and distributors in the United States and in certain international territories. The Company’s core strategy is to enhance and monetize the global reach of its existing brands, and to pursue additional strategic acquisitions to grow the scope of and diversify its portfolio of brands. The Company licenses brands to both wholesale and direct-to-retail licensees. In a wholesale license, a wholesale supplier is granted rights (typically on an exclusive basis) to a single or small group of related product categories for a particular brand for sale to multiple accounts within an approved channel of distribution and territory. In a direct-to-retail license, a single retailer is granted the right (typically on an exclusive basis) to sell branded products in a broad range of product categories through its brick and mortar stores and e-commerce sites. As of September 30, 2018 , the Company had more than one-hundred thirty-five licensees, with wholesale licensees comprising a significant majority. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2018 | |
Summary of Significant Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies |  2. Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and footnotes necessary for a comprehensive presentation of financial position, results of operations or cash flows. It is the Company’s opinion, however, that the accompanying unaudited condensed consolidated financial statements include all adjustments, which are of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 , as filed with the SEC on March 16, 2018, which contains the audited consolidated financial statements and notes thereto, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations, for the years ended December 31, 2017, 2016 and 2015. The financial information as of December 31, 2017 is derived from the audited consolidated financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 . The interim results for the nine months ended September 30, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018 or for any future interim periods.  Reclassification of Prior Year Presentation  On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2016-18 “Statement of Cash Flows (Topic 230): Restricted Cash” (“ASU 2016-18”), which changes the presentation of restricted cash on the statement of cash flows. ASU 2016-18 requires an entity to show the changes in total cash, cash equivalents, restricted cash, and restricted cash equivalents in the statement of cash flows.  As a result of the adoption of ASU 2016-18, the Company no longer shows the changes in restricted cash on the statement of cash flows and reconciles to the total cash and restricted cash balance, which are presented separately on the condensed consolidated balance sheets.  Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.  Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates. Revenue Recognition The Company recognizes revenue in accordance with ASC 606, “Revenue from Contracts with Customers” (“ASC 606”), which became effective for the Company as of January 1, 2018 (See Note 4 for impact of adoption and other related disclosures). ASC 606 requires a five-step approach to determine the appropriate method of revenue recognition for each contractual arrangement:  Step 1: Identify the Contract(s) with a Customer Step 2: Identify the Performance Obligation(s) in the Contract Step 3: Determine the Transaction Price Step 4: Allocate the Transaction Price to the Performance Obligation(s) in the Contract Step 5: Recognize Revenue when (or as) the Entity Satisfies a Performance Obligation  The Company has entered into various license agreements for its owned trademarks. Under ASC 606, the Company’s agreements are generally considered symbolic licenses, which contain the characteristics of a right-to-access license since the customer is simultaneously receiving the intellectual property (“IP”) and benefiting from it throughout the license period. The Company assesses each license agreement at inception and determines the performance obligation(s) and appropriate revenue recognition method. As part of this process, the Company applies judgments based on historical trends when estimating future revenues and the period over which to recognize revenue. The Company generally recognizes revenue for license agreements under the following methods: 1. Licenses with guaranteed minimum royalties (“GMRs”): Generally, guaranteed minimum royalty payments (fixed revenue) are recognized on a straight-line basis over the term of the contract, as defined in each license agreement. 2. Licenses with both GMRs (fixed revenue) and earned royalties (variable revenue): Earned royalties in excess of fixed revenue are only recognized when the Company is reasonably certain that the guaranteed minimum payments for the period, as defined in each license agreement, will be exceeded. Additionally, the Company has categorized certain contracts as variable when there is a history and future expectation of exceeding GMRs. The Company recognizes income for these contracts during the period corresponding to the licensee’s sales. 3. Licenses that are sales-based only or earned royalties: Earned royalties (variable revenue) are recognized as income during the period corresponding to the licensee’s sales.  Payments received as consideration for the grant of a license or advanced royalty payments are recorded as deferred revenue at the time payment is received and recognized into revenue under the methods described above.  Contract assets represent unbilled receivables and are presented within accounts receivable, net on the condensed consolidated balance sheets. Contract liabilities represent unearned revenues and are presented within the current portion of deferred revenue on the condensed consolidated balance sheets.  The Company disaggregates its revenue into two categories: licensing agreements and other, which is comprised of revenue from sources such as editorial content for book s, television sponsorships, sales commissions and vendor placement commissions .  With respect to editorial content for books, the Company receives advance payments from the Company’s publishers and recognizes revenue when manuscripts are delivered to and accepted by the publishers. Revenue is also earned from book publishing when sales on a unit basis exceed the advanced royalty. Television sponsorship revenues are generally recorded ratably across the period when new episodes initially air. Revenue from media content is recognized at a point in time, when the content is delivered and accepted.  Commission revenues and vendor placement commission revenues are recorded in the period the commission is earned.  The Company entered into a transaction with a media company for which it receives advertising credits as part of the consideration exchanged. These transactions are recorded at the estimated fair value of the advertising credits received, as their fair value is deemed more readily determinable than the fair value of the trademark licensing right provided by the Company, in accordance with ASC 845, Nonmonetary Transactions . The fair value of the advertising credits are recorded as revenue and in other assets when earned, and expensed when the advertising credits are utilized. The Company recorded $1.2 million and $1.6 million of revenue for the three and nine months ended September 30, 2018 related to the advertising credits. The Company recorded revenue of $0.8 million for the three and nine months ended September 30, 201 7 related to the advertising credits. The Company recorded $0.6 million and $0.8 million of expense related to the advertising credits utilized for the three and nine months ended September 30, 2018. The Company did not record any expense related to the advertising credits for the three and nine months ended September 30, 2017 as they had not yet been utilized .  Restricted Cash  Restricted cash consists of cash deposited with a financial institution required as collateral for the Company’s cash-collateralized letter of credit facilities.  Accounts Receivable Accounts receivable are recorded net of allowances for doubtful accounts, based on the Company’s ongoing discussions with its licensees and other customers and its evaluation of their creditworthiness, payment history and account aging. Accounts receivable balances deemed to be uncollectible are written off after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $0.5 million and $ 0.6 million as of September 30, 2018 and December 31, 2017, respectively .  The Company’s accounts receivable, net amounted to $63. 5 million and $60.1 million as of September 30, 2018 and December 31, 2017 , respectively. Three licensees accounted for approximately 43% ( 21% , 12% , and 10% ) of the Company’s total consolidated accounts receivable balance as of September 30, 2018 and three licensees accounted for approximately 53% ( 25% , 15% and 13% ) of the Company’s total consolidated accounts receivable balance as of December 31, 2017 . The Company does not believe the accounts receivable balance from these licensees represents a significant collection risk based on past collection experience.  Investments The Company had marketable securities that were classified as available-for-sale securities under ASC 320, Investments – Debt and Equity Securities . Such available-for-sale securities are reported at fair value in the condensed consolidated balance sheets and, at the time of purchase, were reported in the unaudited condensed consolidated statements of cash flows as an investing activity. The Company reviewed its available-for-sale securities at each reporting period to determine whether a decline in fair value is other-than-temporary. Any decline in fair value that was determined to be other-than-temporary would result in an adjustment for an impairment charge in the accompanying unaudited condensed consolidated statements of operations. The primary factors the Company considers in its determination are (i) the length of time that the fair value of the available-for-sale security is below the Company’s carrying value, (ii) the financial condition and operating performance of the available-for-sale security, (iii) the reason for decline in fair value and (iv) the Company’s intent and ability to hold the investment in available-for-sale security for a period of time sufficient to allow for a recovery in fair value. Realized gains and losses from the sale of available-for-sale securities, if any, are determined on a specific-identification basis. The Company did not hold any material investments at September 30, 2018 or December 31, 2017. Equity Method Investment  For investments in entities over which the Company exercises significant influence but which do not meet the requirements for consolidation, the Company uses the equity method of accounting. On July 1, 2016, the Company acquired a 49.9% noncontrolling interest in Gaiam Pty. Ltd. in connection with its acquisition of Gaiam Brand Holdco, LLC, which is included in other assets in the condensed consolidated balance sheets. The Company’s share of earnings from its equity method investee, which was not material for the three and nine months ended September 30, 2018 and 2017, is included in other income in the unaudited condensed consolidated statements of operations.  The Company evaluates its equity method investment for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investment may not be recoverable. The difference between the carrying value of the equity method investment and its estimated fair value is recognized as an impairment charge when the loss in value is deemed other-than-temporary.  Goodwill and Intangible Assets Goodwill represents the excess of purchase price over the fair value of net assets acquired in business combinations accounted for under the purchase method of accounting. The Company does not have any goodwill reported on its consolidated balance sheets at September 30, 2018 and December 31, 2017.  On an annual basis (October 1 st ) and as needed, the Company tests goodwill and indefinite lived trademarks for impairment through the use of discounted cash flow models. Assumptions used in our discounted cash flow models are as follows: (i) discount rates; (ii) projected average revenue growth rates; and (iii) projected long-term growth rates. Our estimates also factor in economic conditions and expectations of management, which may change in the future based on period-specific facts and circumstances. Other intangibles with determinable lives, including certain trademarks, customer agreements, patents and a favorable lease, are evaluated for the possibility of impairment when certain indicators are present, and are otherwise amortized on a straight-line basis over the estimated useful lives of the assets (currently ranging from 2 to 15 years).  During the quarter ended September 30, 2018, the Company recorded non-cash impairment charges of $17.9 million for indefinite-lived intangible assets related to the trademarks of two of the Company’s non-core brands: Caribbean Joe and Ellen Tracy. The impairments arose due to reduced growth expectations and the impact of licensee transitions for these brands. During the quarter ended September 30, 2017, the Company recorded non-cash impairment charges of $36.5 million for indefinite-lived intangible assets related to the trademarks of five of the Company’s non-core brands: Caribbean Joe, Revo, Franklin Mint, Nevados, and FUL. The impairments arose due to reduced contractual minimums or reduced sales forecasts in key distribution channels for these brands. Fair value for each trademark was determined based on the income approach using estimates of future discounted cash flows. These charges are included in impairment charges in the unaudited condensed consolidated statements of operations. See Note 3 and Note 6 for further information. Treasury Stock  Treasury stock is recorded at cost as a reduction of equity in the condensed consolidated balance sheets.  Stock-Based Compensation  Compensation cost for restricted stock is measured using the quoted market price of the Company’s common stock at the date the common stock is granted. For restricted stock and restricted stock units, for which restrictions lapse with the passage of time (“time-based restricted stock”), compensation cost is recognized on a straight-line basis over the period between the issue date and the date that restrictions lapse. Time-based restricted stock is included in total shares of common stock outstanding upon the lapse of applicable restrictions. For restricted stock, for which restrictions are based on performance measures (“performance stock units” or “PSUs”), restrictions lapse when those performance measures have been deemed achieved. Compensation cost for PSUs is recognized on a straight-line basis during the period from the date on which the likelihood of the PSUs being earned is deemed probable and (x) the end of the fiscal year during which such PSUs are expected to vest or (y) the date on which awards of such PSUs may be approved by the compensation committee of the Company’s board of directors (the “Compensation Committee”) on a discretionary basis, as applicable. PSUs are included in total shares of common stock outstanding upon the lapse of applicable restrictions. PSUs are included in total diluted shares of common stock outstanding when the performance measures have been deemed achieved but the PSUs have not yet been issued.  Fair value cost for stock options and warrants is calculated using the Black-Scholes valuation model and is expensed on a straight-line basis over the requisite service period of the grant. Compensation cost is reduced for forfeitures as they occur in accordance with ASU 2016-09 “Simplifying the Accounting for Share-Based Payments” (“ASU 2016-09”) .  At each subsequent reporting period prior to the lapse of restrictions on warrants, time-based restricted stock and PSUs granted to non-employees, the Company remeasures the aggregate compensation cost of such grants using the Company’s fair value at the end of such reporting period and revises the straight-line recognition of compensation cost in line with such remeasured amount.  Leases  The Company leases certain properties for its offices and showrooms. Certain of the Company's lease agreements contain rent escalation clauses, free rent periods and tenant inducement payments. Rent expense for noncancelable operating leases with scheduled rent increases is recognized on a straight-line basis over the expected lease term. The difference between straight-line rent expense and the scheduled payment amounts is recorded as a deferred rent asset or liability.      Income Taxes Current income taxes are based on the respective periods’ taxable income for federal, foreign and state income tax reporting purposes. Deferred tax liabilities and assets are determined based on the difference between the financial statement and income tax bases of assets and liabilities, using statutory tax rates in effect for the year in which the differences are expected to reverse. In accordance with ASU No. 2015-17 “Balance Sheet Classification of Deferred Taxes,” all deferred income taxes are reported and classified as non-current. A valuation allowance is required if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  On December 22, 2017, the SEC staff issued Staff Accounting Bulletin (“SAB”) No. 118 which provides guidance on accounting for the tax effects of the Tax Cuts and Jobs Act ("TCJA"). The purpose of SAB No. 118 was to address any uncertainty or diversity of view in applying “ASC Topic 740”, Income Taxes in the reporting period in which the TCJA was enacted. SAB No. 118 addresses situations where the accounting is incomplete for certain income tax effects of the TJCA upon issuance of a company’s financial statements for the reporting period that includes the enactment date. SAB No. 118 allows for a provisional amount to be recorded if it is a reasonable estimate of the impact of the TCJA. Additionally, SAB No. 118 allows for a measurement period to finalize the impacts of the TCJA, not to extend beyond one year from the date of enactment. The Company’s accounting for certain elements of the TCJA was incomplete as of the period ended December 31, 2017. However, the Company was able to make reasonable estimates of the effects and, therefore, recorded provisional estimates for these items at December 31, 2017.  The Company applies the Financial Accounting Standards Board (“FASB”) guidance on accounting for uncertainty in income taxes. The guidance clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements in accordance with other authoritative GAAP and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The guidance also addresses derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Interest and penalties related to uncertain tax positions, if any, are recorded in income tax expense. Tax years that remain open for assessment for federal and state tax purposes include the years ended December 31, 2014 through December 31, 2017.  Earnings Per Share Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) attributable to Sequential Brands Group, Inc. and Subsidiaries by the weighted-average number of common shares outstanding during the reporting period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the reporting period, including stock options, PSUs and warrants, using the treasury stock method, and convertible debt, using the if-converted method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive. The shares used to calculate basic and diluted EPS consist of the following:     Three Months Ended September 30, Nine Months Ended September 30,  2018 2017 2018 2017   Basic weighted-average common shares outstanding 63,911,481 62,998,944 63,578,121 62,796,716  Warrants - - - -  Stock options - - - -  Performance based restricted stock - - - -  Unvested restricted stock - - - -  Diluted weighted-average common shares outstanding 63,911,481 62,998,944 63,578,121 62,796,716   The computation of diluted EPS for the three and nine months ended September 30, 2018 and 2017 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:   Three Months Ended September 30, Nine Months Ended September 30,  2018 2017 2018 2017   Warrants - 801,760 - 801,760  Stock options - 84,000 - 84,000  Performance based restricted stock 31,162 - 49,202 -  Unvested restricted stock 328,353 972,355 995,568 972,355  Total 359,515 1,858,115 1,044,770 1,858,115   Concentration of Credit Risk Financial instruments which potentially expose the Company to credit risk consist primarily of cash, restricted cash and accounts receivable. Cash is held to meet working capital needs and future acquisitions. Restricted cash is pledged as collateral for a comparable amount of irrevocable standby letters of credit for certain of the Company’s leased properties. Substantially all of the Company’s cash and restricted cash are deposited with high quality financial institutions. At times, however, such cash and restricted cash may be in deposit accounts that exceed the Federal Deposit Insurance Corporation insurance limit. The Company has not experienced any losses in such accounts as of September 30, 2018 .  Concentration of credit risk with respect to accounts receivable is minimal due to the collection history. The Company performs periodic credit evaluations of its customers’ financial condition. The allowance for doubtful accounts is based upon the expected collectability of all accounts receivable.  Customer Concentrations The Company recorded net revenues of $4 0 . 8 million and $39.0 million during the three months ended September 30, 2018 and 2017 , respectively. During the three months ended September 30, 2018 , two licensees represented at least 10% of net revenue, accounting for 15% and 10% of the Company’s net revenue. During the three months ended September 30, 2017 , three licensees represented at least 10% of net revenue, accounting for 12% , 11% , and 10% of the Company’s net revenue.  The Company recorded net revenues of $121. 1 million and $120.6 million during the nine months ended September 30, 2018 and 2017, respectively. During the nine months ended September 30, 2018, two licensees represented at least 10% of net revenue, accounting for 13% and 10% of the Company’s net revenue. During the nine months ended September 30, 2017, three licensees represented at least 10% of net revenue, accounting for 11% , 11% , and 10% of the Company’s net revenue.  Loss Contingencies The Company recognizes contingent losses that are both probable and estimable. In this context, probable means circumstances under which events are likely to occur. The Company records legal costs pertaining to contingencies as incurred.  Contingent Consideration  The Company recognizes the acquisition-date fair value of contingent consideration as part of the consideration transferred in exchange for the acquiree or assets of the acquiree in a business combination. The contingent consideration is classified as either a liability or equity in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity . If classified as a liability, the liability is remeasured to fair value at each subsequent reporting date until the contingency is settled. Increases in fair value are recorded as losses, while decreases are recorded as gains. If classified as equity, contingent consideration is not remeasured and subsequent settlement is accounted for within equity.  Noncontrolling Interest  Noncontrolling interest recorded for the three and nine months ended September 30, 2018 represents income allocations to Elan Polo International, Inc., a member of DVS Footwear International, LLC, With You, Inc., a member of With You LLC (the partnership between the Company and Jessica Simpson) and JALP, LLC (“JALP”), a member of FUL IP Holdings, LLC (“FUL IP”). Noncontrolling interest recorded for the three and nine months ended September 30, 2017 represents income allocations to Elan Polo International, Inc., With You, Inc. and JALP.  Reportable Segment An operating segment, in part, is a component of an enterprise whose operating results are regularly reviewed by the chief operating decision maker (the “CODM”) to make decisions about resources to be allocated to the segment and assess its performance. Operating segments may be aggregated only to a limited extent. The Company’s CODM, the Chief Executive Officer, reviews financial information presented on a consolidated basis, accompanied by disaggregated information about revenues for purposes of making operating decisions and assessing financial performance. Accordingly, the Company has determined that it has a single operating and reportable segment. In addition, the Company has no foreign office s or any assets i n foreign locations. The majority of the Company’s operations consist of a single revenue stream, which is the licensing of its trademark portfoli o, with additional revenues derived from television, book, café operations and certain commissions. |
Fair Value Measurement of Finan
Fair Value Measurement of Financial Instruments | 9 Months Ended |
Sep. 30, 2018 | |
Fair Value Measurement of Financial Instruments [Abstract] | |
Fair Value Measurement of Financial Instruments |  3. Fair Value Measurement of Financial Instruments ASC 820-10, Fair Value Measurements and Disclosures (“ASC 820-10”), defines fair value, establishes a framework for measuring fair value in GAAP and provides for expanded disclosure about fair value measurements. ASC 820-10 applies to all other accounting pronouncements that require or permit fair value measurements.  The Company determines or calculates the fair value of financial instruments using quoted market prices in active markets when such information is available or using appropriate present value or other valuation techniques, such as discounted cash flow analyses, incorporating available market discount rate information for similar types of instruments while estimating for non-performance and liquidity risk. These techniques are significantly affected by the assumptions used, including the discount rate, credit spreads and estimates of future cash flows.  Assets and liabilities typically recorded at fair value on a non-recurring basis to which ASC 820-10 applies include:  • non-financial assets and liabilities initially measured at fair value in an acquisition or business combination, and • long-lived assets measured at fair value due to an impairment assessment under ASC 360-10-15, Impairment or Disposal of Long-Lived Assets .  This topic defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and establishes a three-level hierarchy, which encourages an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820-10 requires that assets and liabilities recorded at fair value be classified and disclosed in one of the following three categories:   • Level 1 - inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. • Level 2 - inputs utilize other-than-quoted prices that are observable, either directly or indirectly. Level 2 inputs include quoted prices for similar assets and liabilities in active markets, and inputs such as interest rates and yield curves that are observable at commonly quoted intervals. • Level 3 - inputs are unobservable and are typically based on the Company’s own assumptions, including situations where there is little, if any, market activity. Both observable and unobservable inputs may be used to determine the fair value of positions that are classified within the Level 3 classification.  In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the Company classifies such financial assets or liabilities based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.  During the three months ended September 30, 2018, the Company recorded non-cash impairment charges of $17.9 million for indefinite-lived intangible assets related to the trademarks of two of the Company’s non-core brands: Ellen Tracy and Caribbean Joe. The impairments arose due to reduced growth expectations and the impact of licensee transitions for these brands. Fair value for each trademark was determined based on the income approach using estimates of future discounted cash flows, a Level 3 measure ment wi thin the fair value hierarchy. The following table shows the change in indefinite-lived intangible assets for the nine months ended September 30, 2018 (in thousands):    Balance at January 1, 2018 $ 990,677  Additions 199  Impairment charges (17,899)  Sale of trademarks (11,170)  Ending balance at September 30, 2018 $ 961,807   During the three months ended September 30, 2017, the Company recorded non-cash impairment charges of $36.5 million for indefinite-lived intangible assets related to the trademarks of five of the Company’s non-core brands: Caribbean Joe , Revo , Franklin Mint , Nevados , and FUL . Fair value for each trademark was determined based on the income approach using estimates of future discounted cash flows, a Level 3 measure ment within the fair value hierarchy. The impairments arose due to reduced contractual minimums or reduced sales forecasts in key distribution channels for these brands. When an intangible asset’s useful life is no longer considered to be indefinite, it must be amortized over the remaining period that it is expected to contribute to cash flows. The Company determined that certain trademarks which had been impaired during the three months ended September 30, 2017 should no longer be classified as indefinite-lived intangible assets. The following table shows the change in indefinite-lived intangible assets for the year ended December 31, 2017 (in thousands):     Balance at January 1, 2017 $ 1,025,260  Additions 2,383  Impairment charges (36,505)  Reclassified to finite-lived intangible assets (461)  Ending balance at December 31, 2017 $ 990,677  As of September 30, 2018 and December 31, 2017 , there were no assets or liabilities that are required to be measured at fair value on a recurring basis, except for interest rate caps and Legacy Payments (as defined below) to Ms. Martha Stewart. The following table sets forth the carrying value and the fair value of the Company’s financial assets and liabilities required to be disclosed at September 30, 2018 and December 31, 2017 :     Carrying Value Fair Value  Financial Instrument Level 9/30/2018 12/31/2017 9/30/2018 12/31/2017  (in thousands)  Interest rate caps 2 $ 542 $ 1,239 $ 542 $ 1,239  2016 Term Loans 2 $ 526,925 $ 551,913 $ 524,176 $ 542,655  2016 Revolving Loan 2 $ 115,000 $ 92,787 $ 114,837 $ 92,389  Legacy Payments 3 $ 2,479 $ 2,256 $ 2,479 $ 2,256  The carrying amounts of the Company’s cash, restricted cash, accounts receivable and accounts payable approximate fair value due to their short-term maturities.  During 2016, the Company entered into interest rate cap agreements related to its 1-month London Interbank Offered Rate (“LIBOR”) rates related to the Company’s loan agreements (the “2016 Cap Agreements”) with certain financial institutions. The 2016 Cap Agreements have a $500 million notional value, strike rate of 1.50% and mature on November 23, 2018 . The Company recorded its interest rate caps on the condensed consolidated balance sheets at fair value using Level 2 inputs. The valuation technique used to determine the fair value of the 2016 Cap Agreements approximated the net present value of future cash flows, taking into account current interest rates.  The Company’s risk management objective and strategy with respect to the 2016 Cap Agreements is to reduce its exposure to variability in expected future cash outflows (forecasted interest payments) attributable to changes in 1-month LIBOR rates, the designated benchmark interest rate being hedged, relating to a portion of its outstanding floating-rate debt. The 2016 Cap Agreements protect the Company from increases in hedged cash flows on its floating-rate debt attributable to changes in 1-month LIBOR rates above the strike rate. Should 1-month LIBOR rates exceed 1.50% on a rate reset date during the terms of the 2016 Cap Agreements, the financial institutions will pay the Company for an amount equivalent to the excess interest over the strike rate. To the extent the hedging relationship is perfectly effective, changes in the fair value of the hedging instrument each period will be deferred in accumulated other comprehensive income in the condensed consolidated statement of changes in equity, and the upfront hedging instrument purchase price will be reclassified to interest expense, net in the unaudited condensed consolidated statements of operations according to its caplet values. If hedge ineffectiveness exists, accumulated other comprehensive income will be adjusted to a balance that reflects the lesser of either the cumulative change in the fair value of the hedging or the cumulative change in the fair value of the hypothetically “perfect” derivative. The amount of ineffectiveness, if any, recorded in earnings would be equal to the excess of the cumulative change in the fair value of the hedging instrument over the cumulative change in the fair value of the hypothetical derivative.     The components of the 2016 Cap Agreements as of September 30, 2018 are as follows:     Notional Value Derivative Asset Derivative Liability   (in thousands)   LIBOR based loans $ 500,000 $ 249 $ -  For purposes of this fair value disclosure, the Company based its fair value estimate for the 2016 Term Loans and 2016 Revolving Loan (each, as defined in Note 7 – both under and prior to the amendment ) on its internal valuation whereby the Company applied the discounted cash flow method to its expected cash flow payments due under the loan agreements based on interest rates as of September 30, 2018 and December 31, 2017 for debt with similar risk characteristics and maturities.  In connection with the acquisition of Martha Stewart Living Omnimedia (“MSLO”), beginning with calendar years commencing on or after January 1, 2026, the Company will pay Ms. Stewart three and one-half percent ( 3.5% ) of Gross Licensing Revenues (as defined in Ms. Stewart’s employment agreement) for each such calendar year for the remainder of Ms. Stewart’s life (with a minimum of five ( 5 ) years of payments, to be made to Ms. Stewart’s estate if Ms. Stewart dies before December 31, 2030) (the “Legacy Payments”). The Company recorded $0.1 million of accretion during each of the three months ended September 30, 2018 and 2017 and $0.2 million during each of the nine months ended September 30, 2018 and 2017 related to the Legacy Payments and recorded the expense within interest expense, net in the unaudited condensed consolidated statements of operations. |
Revenues
Revenues | 9 Months Ended |
Sep. 30, 2018 | |
Revenues [Abstract] | |
Revenue |   4. Revenues  Adoption On January 1, 2018, the Company adopted ASC 606 on a modified retrospective basis for all open contracts as of January 1, 2018. The core principle of the new guidance is the recognition of revenue when a company transfers promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled to in exchange for those goods or services. The new guidance defines a five-step approach to achieve this core principle and, in doing so, requires greater use of judgment and estimates and requires expanded disclosures related to the amounts of revenue recognized and judgements made. Under the modified retrospective basis, results for reporting periods beginning after January 1, 2018 are presented under the new revenue standard, while prior period amounts are not adjusted and continue to be reported in accordance with ASC 605, “Revenue Recognition” (“ASC 605”).  In connection with the adoption of the new guidance, the Company recorded a net increase of $1.1 million to the opening balance of retained earnings (a reduction of the accumulated deficit). The adjustments consisted of increases of $6.3 million to accounts receivable (resulting in unbilled receivables) and $4.4 million to deferred revenue (contract liability) offset by a noncontrolling interests opening balance adjustment of $0.4 million and an income tax impact of $0.5 million. The adjustments are recorded in the condensed consolidated financial statements as the cumulative effect of revenue recognition accounting change.  Changes to the balances at January 1, 2018 resulting from the adoption of ASC 606 are as follows:     December 31, Impact of January 1,  2017 (As Reported) Adoption of ASC 606 2018  (in thousands)  Assets  Current Assets:  Accounts receivable, net $ 60,102 $ 6,335 $ 66,437  Liabilities  Current Liabilities:  Current portion of deferred revenue $ 8,102 $ 4,387 $ 12,489  Deferred income taxes 67,799 463 68,262  Equity  Accumulated deficit $ (225,369) $ 1,130 $ (224,239)  Noncontrolling interests 71,547 355 71,902 Deferred revenue will be recognized as the Company fulfills its performance obligations over periods of approximately one to five years.  The impact to revenue for the three and nine months ended September 30, 2018 was a decrease of $0. 5 million and $2. 5 million , re spectively, due to the adoption of ASC 606 . The impact to the benefit from income taxes for the three and n i ne months ended September 30, 2018 was a decrease of $0.2 million and $0.6 million , respectively, due to t he adoption of ASC 606 . The tables below summarize the impact of the adoption on the condensed consolidated statement s o f operations for the three and nine months ended September 30, 2018:    Three Months Ended September 30,  2018  (in thousands)  As Reported Adjustments due to ASC 606 Under previous guidance (ASC 605)   Net revenue $ 40,771 $ (464) $ 41,235  Operating expenses 23,515 - 23,515  Impairment charges 17,899 - 17,899  Loss from operations (643) (464) (179)  Other income (31) - (31)  Interest expense, net 15,635 - 15,635  Loss before income taxes (16,247) (464) (15,783)  Benefit from income taxes (8,213) (155) (8,058)  Net loss (8,034) (309) (7,725)  Net income attributable to noncontrolling interests (1,581) 4 (1,585)  Net loss attributable to Sequential Brands Group, Inc. and Subsidiaries $ (9,615) $ (305) $ (9,310)   Loss per share attributable to Sequential Brands Group, Inc. and Subsidiaries:  Basic and diluted $ (0.15) $ (0.00) $ (0.15)   Weighted-average common shares outstanding:  Basic and diluted 63,911,481 63,911,481 63,911,481    Nine Months Ended September 30,  2018  (in thousands)  As Reported Adjustments due to ASC 606 Under previous guidance (ASC 605)   Net revenue $ 121,082 $ (2,509) $ 123,591  Operating expenses 60,014 - 60,014  Impairment charges 17,899 - 17,899  Loss on sale of assets 7,117 - 7,117  Income from operations 36,052 (2,509) 38,561  Other income (135) - (135)  Interest expense, net 46,674 - 46,674  Loss before income taxes (10,487) (2,509) (7,978)  Benefit from income taxes (6,838) (577) (6,261)  Net loss (3,649) (1,932) (1,717)  Net income attributable to noncontrolling interests (4,643) 184 (4,827)  Net loss attributable to Sequential Brands Group, Inc. and Subsidiaries $ (8,292) $ (1,748) $ (6,544)   Loss per share attributable to Sequential Brands Group, Inc. and Subsidiaries:  Basic and diluted $ (0.13) $ (0.03) $ (0.10)   Weighted-average common shares outstanding:  Basic and diluted 63,578,121 63,578,121 63,578,121  Disaggregated Revenue The following table presents revenue disaggregate d by source for the three and nine months ended September 30, 2018:     Three Months Ended September 30, Nine Months Ended September 30,  2018 2018  (in thousands)   Licensing Agreements $ 37,669 $ 112,995  Other 3,102 8,087  Total $ 40,771 $ 121,082  The Company has entered into various license agreements that provide revenues in exchange for use of the Company’s IP. Licensing agreements are the Company’s primary source of revenue. The Company also derives revenue from other sources such as editorial content for books, television sponsorships , commissions and vendor placement commissions .  Contract Balances  Contract assets represent unbilled receivables and are presented within accounts receivable, net on the condensed consolidated balance sheets. Contract liabilities represent unearned revenues and are presented within the current portion of deferred revenue on the condensed consolidated balance sheets.  The below table summarizes the net change in contract assets and contract liabilities from the date of adoption to September 30, 2018:    January 1, September 30,  2018 Changes 2018  (in thousands)   Contract assets $ 6,335 $ (2,303) $ 4,032  Contract liabilities 4,387 206 4,593      Performance Obligations A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. The Company has reviewed its various revenue streams for its existing contracts under the five-step approach. The Company has entered into various license agreements that provide revenues based on guaranteed minimum royalty payments with additional royalty revenues based on a percentage of defined sales. Guaranteed minimum royalty payments (fixed revenue) are recognized on a straight-line basis over the term of the contract, as defined in each license agreement. Earned royalties and earned royalties in excess of the fixed revenue (variable revenue) are recognized as income during the period corresponding to the licensee’s sales. Earned royalties in excess of fixed revenue are only recognized when the Company is reasonably certain that the guaranteed minimums payments for the period, as defined in each license agreement, will be exceeded.  Licensing for trademarks is the Company’s largest revenue source. Under ASC 606, the Company’s agreements are generally considered symbolic licenses which contain the characteristics of a right-to-access license since the customer is simultaneously receiving the IP and benefiting from it throughout the license period. As such, the Company primarily records revenue from licenses on a straight-line basis over the license period as the performance obligation is satisfied over time. The Company applies its judgment based on historical trends when estimating future revenues and the period over which to recognize revenue when evaluating its licensing contracts.  The below table summarizes amounts related to future performance obligations under fixed contractual arrangements as of September 30, 2018 and the periods in which they are expected to be earned and recognized as revenue:     Remainder of 2018 2019 2020 2021 2022 and Thereafter  Future Performance Obligations $ 22,418 $ 69,800 $ 54,261 $ 38,771 $ 55,835  The Company does not disclose the amount attributable to unsatisfied or partially satisfied performance obligations for variable revenue contracts in accordance with the optional exemption allowed for under ASC 606. The Company has categorized certain contracts as variable when there is a history and future expectation of exceeding guaranteed minimum royalties. |
Goodwill
Goodwill | 9 Months Ended |
Sep. 30, 2018 | |
Goodwill [Abstract] | |
Goodwill |   5. Goodwill Previous changes in goodwill are summarized as follows (in thousands) :      Balance at January 1, 2017 $ 307,744  (Adjustment for) acquisition of Gaiam Brand Holdco, LLC (a) (3,621)  Impairment charges (304,123)  Balance at December 31, 2017 $ -  (a) Goodwill from the acquisition of Gaiam Brand Holdco, LLC represents the excess of the purchase price over the fair value of net assets acquired under the acquisition method of accounting.  Goodwill represents the excess of the purchase price over the fair value of net assets acquired under the acquisition method of accounting. Goodwill is tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. In evaluating goodwill for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Qualitative factors considered include, for example, macroeconomic and industry conditions, overall financial performance and other relevant entity-specific events. If the Company bypasses the qualitative assessment, or concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, it then performs a goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment to be recognized, if any.  The Company will compare the estimated fair value of the reporting unit with its carrying value. The Company has determined it has a single reporting unit. Fair value for the quantitative assessment is determined under an income approach using estimates of discounted future cash flows (the “Income Approach”). The Income Approach relies on assumptions such as the Company’s projected future earnings and appropriate discount rates.    Significant assumptions used in the Income Approach are as follows: (i) discount rates; (ii) projected annual revenue growth rates; and (iii) projected long-term growth rates. The Company’s estimates also factor in economic conditions and expectations of management which may change in the future based on period-specific facts and circumstances. The Company will corroborate the results of the Income Approach by reconciling to within a reasonable range of the Company’s market capitalization, (calculated as total common shares outstanding multiplied by the common equity price per share, as adjusted for a control premium factor). The control premium is estimated based upon control premiums observed in comparable market transactions.  If the estimated fair value of the reporting unit exceeds its carrying amount, no further analysis is needed. If, however, the estimated fair value of the reporting unit is less than its carrying amount, the Company will recognize an impairment change for the amount by which the carrying value exceeds the reporting unit’s fair value . |
Intangible Assets
Intangible Assets | 9 Months Ended |
Sep. 30, 2018 | |
Intangible Assets [Abstract] | |
Intangible Assets |  6. Intangible Assets Intangible assets are summarized as follows:     September 30, 2018 Useful Lives (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount   (in thousands)  Finite-lived intangible assets:  Trademarks 15 $ 5,474 $ (2,234) $ 3,240  Customer agreements 4 2,832 (2,562) 270  Favorable lease 2 537 (537) -  Patents 10 361 (318) 43  $ 9,204 $ (5,651) 3,553  Indefinite-lived intangible assets:  Trademarks 961,807   Intangible assets, net $ 965,360  \    December 31, 2017 Useful Lives (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount   (in thousands)  Finite-lived intangible assets:  Trademarks 15 $ 5,462 $ (1,913) $ 3,549  Customer agreements 4 2,832 (2,257) 575  Favorable lease 2 537 (537) -  Patents 10 665 (296) 369  $ 9,496 $ (5,003) 4,493  Indefinite-lived intangible assets:  Trademarks 990,677   Intangible assets, net $ 995,170   Estimated future annual amortization expense for intangible assets in service as of September 30, 2018 is summarized as follows:     Years ending December 31, (in thousands)  Remainder of 2018 $ 185  2019 627  2020 439  2021 436  2022 413  Thereafter 1,453  $ 3,553  Amortization expense amounted to $0.2 million for each of the three months ended September 30, 2018 and 2017 . Amortization expense amounted to $0.6 million and $0.7 million for the nine months ended September 30, 2018 and 2017 , respectively .  Finite-lived intangible assets represent trademarks, customer agreements and patents related to the Company’s brands and a favorable lease. Finite-lived intangible assets are amortized on a straight-line basis over the estimated useful lives of the assets. The carrying value of finite-lived intangible assets and other long-lived assets is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are not amortized, but instead are subject to impairment evaluation. As of September 30, 2018, t he trademarks of Martha Stewart , Jessica Simpson , Avia , AND1 , Heelys , Joe’s Jeans , GAIAM , Emeril , Caribbean Joe , and Ellen Tracy have been determined to have an indefinite useful life , and accordingly, consistent with ASC Topic 350, no amortization has been recorded in the Company’s unaudited condensed consolidated statements of operations. Instead, each of these intangible assets are tested for impairment annually and as needed on an individual basis as separate single units of accounting, with any related impairment charge recorded to the statement of operations at the time of determining such impairment. The annual evaluation of the Company’s indefinite-lived trademarks is performed as of October 1, the beginning of the Company’s fourth fiscal quarter. Based on the Company’s annual evaluation, t he Company determined that a certain trademark should no longer be classified as an in definite-lived intangible asset and beginning in the fourth quarter 2018 will be reclassified as a finite-lived intangible asset and amortized on a straight-line basis over the remaining estimated useful life of the trademark . During the nine months ended September 30, 2018 , the Company recorded non-cash impairment charges of $17.9 million for indefinite-lived intangible assets r elated to the trademarks of two of the Company’s non-core brands: Caribbean Joe and Ellen Tracy . The impairments arose due to reduced growth expectations and the impact of licensee transitions for these brands identified during the annual budget process which began at the end of the third quarter 2018 . During the nine months ended September 30, 2017, the Company recorded non-cash impairment charges of $36.5 million for indefinite-lived intangible assets related to the trademarks of five of the Company’s non-core brands: Caribbean Joe , Revo , Franklin Mint , Nevados , and FUL . The impairments arose due to reduced contractual minimums or reduced sales forecasts in key distribution channels for these brands. Fair value for each trademark was determined based on the income approach using estimates of future discounted cash flows. These charge s are included in impairment charges in the unaudited condensed consolidated statements of operations.  D uring the nine months ended September 30, 2018, the Company sold both the Revo and FUL trademarks. During the nine months ended September 30, 2018, the Company incurred a loss on the sale of the assets of $7.1 million. The following table shows the change in indefinite-lived intangible assets for the nine months ended September 30, 2018 (in thousands):     Balance at January 1, 2018 $ 995,170  Impairment of trademarks (17,899)  Sale of trademarks (11,473)  Amortization (648)  Additions 210  Balance at September 30, 2018 $ 965,360  |
Long-Term Debt
Long-Term Debt | 9 Months Ended |
Sep. 30, 2018 | |
Long-Term Debt [Abstract] | |
Long-Term Debt |  7. Long-Term Debt  The components of long-term debt are as follows:    September 30, December 31,  2018 2017   (in thousands)   2016 Term Loans $ 526,925 $ 551,913  2016 Revolving Loan 115,000 92,787  Unamortized deferred financing costs (25,399) (14,103)  Total long-term debt, net of unamortized deferred financing costs 616,526 630,597  Less: current portion of long-term debt 28,300 28,300  Long-term debt $ 588,226 $ 602,297   July 2016 Debt Facilities (under the New Amended Agreements – defined below)  On August 7, 2018, the Company and certain of its subsidiaries amended its (i) Third Amended and Restated First Lien Credit Agreement (the “New Amended BoA Credit Agreement”) with Bank of America, N.A., as administrative agent and collateral agent and the lenders party thereto (the “BoA Facility Loan Parties”) and (ii) the Third Amended and Restated Credit Agreement (the “New Amended FS/KKR Credit Agreement”) with Wilmington Trust, National Association, as administrative agent and collateral agent (the “FS/KKR Agent”) and the lenders party thereto (the “FS/KKR Facility Loan Parties”). The Company used a portion of the proceeds of the $335.0 million loans made to the Company under the New Amended BoA Credit Agreement to prepay loans under the Amended FS/KKR Credit Agreement.  During the three months ended September 30, 2018, the Company incurred $14.6 million in lender and certain third-party fees associated with debt refinancing which was recorded as deferred financing costs in accordance with ASC 470 – Debt and included in Long-term debt, net of current portion in the condensed consolidated balance sheets. These fees are being amortized using the effective interest rate method over the terms of the New Amended BoA Credit Agreement and New Amended FS/KKR Credit Agreement. The Company expensed $0.1 million of deferred financing costs, included in Interest Expense, net in the unaudited condensed consolidated statement of operations, as a result of a partial extinguishment of the Amended BoA Credit Agreement in accordance with ASC 470 – Debt in connection with the Company’s entry into the New Amended BoA Credit Agreement.  The New Amended BoA Credit Agreement provides for several five -year senior secured credit facilities, consisting of (i) Tranche A Term Loans in an aggregate principal amount of $150.0 million (the “Amended Tranche A Loans”), (ii) Tranche A-1 Term Loans in an aggregate principal amount of $70.0 million (the “Amended Tranche A-1 Loans” and, together with the Tranche A Loans, the “Amended BoA Term Loans”) and (iii) revolving credit commitments in the aggregate principal amount of $130.0 million (the “Amended Revolving Credit Commitments” and, the loans under the Revolving Credit Commitments, the “Amended Revolving Loans”). On the Closing Date, the total amount outstanding under the New Amended BoA Credit Agreement was $335.0 million, including (i) $150.0 million of Amended Tranche A Loans, (ii) $70.0 million of Amended Tranche A-1 Loans and (iii) $115.0 million of Amended Revolving Loans.  The loans under the New Amended BoA Credit Agreement bear interest, at the Company’s option, at a rate equal to (i) with respect to the Amended Revolving Loans and the Amended Tranche A Loans (a) the LIBOR rate plus 3.50% per annum or (b) the base rate plus 2.50% per annum and (ii) with respect to the Amended Tranche A-1 Loans (a) the LIBOR rate plus 7.00% per annum or (b) the base rate plus 6.00% per annum. The loans under the New Amended BoA Credit Agreement provide for interest rate reductions if certain leverage ratios are achieved, with minimum interest rates equal to (i) with respect to the Amended Revolving Loans and the Amended Tranche A Loans (a) the LIBOR rate plus 3.00% per annum or (b) the base rate plus 2.00% per annum and (ii) with respect to the Amended Tranche A-1 Loans (a) the LIBOR rate plus 6.00% per annum or (b) the base rate plus 5.00% per annum. The undrawn portions of the Revolving Credit Commitments are subject to a commitment fee of 0.375% per annum.  The Company may make voluntary prepayments of the loans outstanding under the New Amended BoA Credit Agreement, subject to the payment of customary “breakage” costs with respect to LIBOR-based borrowings and, in certain cases, to the prepayment premium set forth in the New Amended BoA Credit Agreement. Additionally, the Company is mandated to make prepayments (without payment of a premium or penalty) under the New Amended BoA Credit Agreement amounting to: (i) the loans outstanding under the New Amended BoA Credit Agreement plus, (a) where intellectual property is disposed, 50.0% of the disposed intellectual property’s orderly liquidation value, and (b) where any other assets constituting collateral are disposed or upon the receipt of certain insurance proceeds, 100% of the net proceeds thereof, subject to certain reinvestment rights; and (ii) the Amended Tranche A-1 Loans to the extent that the outstanding principal amount thereof exceeds 15.0% of the orderly liquidation value of the registered trademarks owned by the BoA Facility Loan Parties. The Amended BoA Term Loans will continue to amortize in quarterly installments of $5.0 million.  The New Amended BoA Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the BoA Facility Loan Parties and their subsidiaries. Moreover, the New Amended BoA Credit Agreement contains financial covenants that require the BoA Facility Loan Parties and their subsidiaries to (i) maintain a positive net income, (ii) satisfy a maximum loan to value ratio initially set at 50.0% (applicable to the Amended Revolving Loans and Amended Tranche A Loans) decreasing over the term of the New Amended BoA Credit Agreement until reaching a final maximum loan to value ratio of 42.5% and (iii) satisfy a maximum consolidated first lien leverage ratio, initially set at 3.875 :1.00, decreasing over the term of the New Amended BoA Credit Agreement until reaching a final maximum ratio of 2.875 :1.00 for the fiscal quarter ending September 30, 2022 and thereafter.  The New Amended BoA Credit Agreement contains certain customary events of default, including a change of control. If an event of default occurs and is not cured within any applicable grace period or not waived, the Bank of America Agent, at the request of the lenders under the New Amended BoA Credit Agreement, must take various actions, including, without limitation, the acceleration of all amounts due under the New Amended BoA Credit Agreement.  The Company may request an increase in (i) the Revolving Credit Facility and Tranche A Loans as would not cause the consolidated first lien leverage ratio, determined on a pro forma basis after giving effect to any such increase, to exceed 2.80 :1.00 and (ii) the Tranche A-1 Loans, as would not cause the consolidated first lien leverage ratio, determined on a pro forma basis after giving effect to any such increase, to exceed (a) with respect to any increase, the proceeds of which will be used solely to finance an acquisition, 3.00:1.00 and (b) with respect to any other increase, 2.90:1.00, subject to the satisfaction of certain conditions in the New Amended BoA Credit Agreement. At September 30, 2018, the Company is in compliance with the covenants included in the New Amended BoA Credit Agreement.     The New Amended FS/KKR Credit Agreement provides for a five and a half-year $314.0 million senior secured term loan facility. The Company may request one or more additional term loan facilities or the increase of term loan commitments under the New Amended FS/KKR Credit Agreement as would not have caused the consolidated total leverage ratio, determined on a pro forma basis after giving effect to any such addition and increase, to exceed 6.00 :1.00, subject to the satisfaction of certain conditions in the New Amended FS/KKR Credit Agreement.  The loans under the New Amended FS/KKR Credit Agreement bear interest, at the Company’s option, at a rate equal to either (i) the LIBOR rate plus 8.75% per annum or (ii) the base rate plus 7.75% per annum.  The Company may make voluntary prepayments of the loans outstanding under the New Amended FS/KKR Credit Agreement, subject to the payment of customary “breakage” costs with respect to LIBOR-based borrowings and, in certain cases, to the prepayment premium set forth in the New Amended FS/KKR Credit Agreement. The Company is mandated to make prepayments (without payment of a premium or penalty) of loans outstanding under the New Amended FS/KKR Credit Agreement amounting to: (i) where intellectual property was disposed, 50.0% of the disposed intellectual property’s orderly liquidation value, (ii) where any other asset constituting collateral is disposed or upon the receipt of certain insurance proceeds, 100% of the net proceeds thereof, subject to certain reinvestment rights, and (iii) any consolidated excess cash flow, in an amount equal to (a) in the event the consolidated total leverage ratio was at least 4.00 :1.00, 75% thereof, (b) in the event the consolidated total leverage ratio was less than 4.00 :1.00 but at least 3.00 :1.00, 50% thereof and (c) in the event the consolidated total leverage ratio was less than 3.00 :1.00, 0% thereof. The loans under the New Amended FS/KKR Credit Agreement will continue to amortize in quarterly installments of approximately $2.1 million.  The New Amended FS/KKR Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the FS/KKR Facility Loan Parties and their subsidiaries. Moreover, the New Amended FS/KKR Credit Agreement contains financial covenants that require the FS/KKR Facility Loan Parties and their subsidiaries to satisfy (i) a maximum consolidated total leverage ratio, initially set at 7.25:1.00, decreasing over the term of the New Amended FS/KKR Credit Agreement until reaching a final maximum ratio of 6.25:1.00 for the fiscal quarter ending September 30, 2022 and thereafter and (ii) a maximum consolidated first lien leverage ratio, initially set at 3.875:1.00, decreasing over the term of the New Amended FS/KKR Credit Agreement until reaching a final maximum ratio of 2.875:1.00 for the fiscal quarter ending September 30, 2022 and thereafter. At September 30, 2018 , the Company is in compliance with the covenants included in the New Amended FS/KKR Credit Agreement.  The New Amended FS/KKR Credit Agreement contains certain customary events of default, including a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the FS/KKR Agent, at the request of the lenders under the New Amended FS/KKR Credit Agreement, is required to take various actions, including, without limitation, the acceleration of amounts due thereunder.  The Company may request one or more additional term loan facilities or the increase of term loan commitments under the New Amended FS/KKR Credit Agreement as would not have caused the consolidated total leverage ratio, determined on a pro forma basis after giving effect to any such addition and increase, to exceed 6.00 :1.00, subject to the satisfaction of certain conditions in the New Amended FS/KKR Credit Agreement.  July 2016 Debt Facilities (prior to New Amended Agreements)  On July 1, 2016 (the “Closing Date”), the Company and certain of its subsidiaries entered into (i) the Third Amended and Restated First Lien Credit Agreement (the “Amended BoA Credit Agreement ”) with Bank of America, N.A., as administrative agent and collateral agent and the lenders party thereto and (ii) the Third Amended and Restated Credit Agreement (the “Amended FS/ KKR Credit Agreement ”) with Wilmington Trust, National Association, as administrative agent and collateral agent and the lenders party thereto. Such agreements amended, restated and replaced the Company’s previous debt facilities. The Company used a portion of the proceeds of the $287.5 million loans made to the Company under the Amended BoA Credit Agreement and the $415.0 million loans made to the Company under the Amended FS/KKR Credit Agreement to fund the payment of the purchase price with respect to the acquisition of the Gaiam Brand Holdco, LLC and costs and expenses incurred in connection with such acquisition and related transactions.  The Amended BoA Credit Agreement provided for several five -year credit facilities, consisting of (i) Tranche A Term Loans in an aggregate principal amount of $133.0 million (the “ Tranche A Loans ”), (ii) Tranche A-1 Term Loans in an aggregate principal amount of $44.5 million (the “ Tranche A-1 Loans ” and, together with the Tranche A Loans, the “ BoA Term Loans ”) and (iii) revolving credit commitments in the aggregate principal amount of $110.0 million (the “ Revolving Credit Facility ” and, the loans under the Revolving Credit Facility, the “ Revolving Loans ”). On the Closing Date, the total amount outstanding under the Amended BoA Credit Agreement was $258.0 million, including (i) $133.0 million of Tranche A Loans, (ii) $44.5 million of Tranche A-1 Loans and (iii) $80.5 million of borrowing under the Revolving Loans.   The loans under the Amended BoA Credit Agreement bore interest, at the Company’s option, at a rate equal to (i) with respect to the Revolving Loans and the Tranche A Loans (a) the LIBOR rate plus 3.50% per annum or (b) the base rate plus 2.50% per annum and (ii) with respect to the Tranche A-1 Loans (a) the LIBOR rate plus 7.00% per annum or (b) the base rate plus 6.00% per annum. The undrawn portions of the commitments under the Revolving Credit Facility were subject to a commitment fee of 0.375% per annum.  The Company could have made voluntary prepayments of the loans outstanding under the Amended BoA Credit Agreement, subject to the payment of customary “breakage” costs with respect to LIBOR-based borrowings and, in certain cases, to the prepayment premium set forth in the Amended BoA Credit Agreement. Additionally, the Company was mandated to make prepayments (without payment of a premium or penalty) under the Amended BoA Credit Agreement amounting to: (i) the loans outstanding under the Amended BoA Credit Agreement plus, (a) where intellectual property is disposed, 50.0% of the disposed intellectual property’s orderly liquidation value, and (b) where any other assets constituting collateral are disposed or upon the receipt of certain insurance proceeds, 100% of the net proceeds thereof, subject to certain reinvestment rights; and (ii) the Tranche A-1 Loans to the extent that the outstanding principal amount thereof exceeds 10.0% of the orderly liquidation value of the registered trademarks owned by the BoA Facility Loan Parties. O n September 30, 2016 , the BoA Term Loans commenced amortization in quarterly installments of $5.0 million.  The Amended BoA Credit Agreement contained customary representations and warranties and customary affirmative and negative covenants applicable to the BoA Facility Loan Parties and their subsidiaries. Moreover, the Amended BoA Credit Agreement contained financial covenants that required the BoA Facility Loan Parties and their subsidiaries to (i) maintain a positive net income (as defined in the agreement), (ii) satisfy a maximum loan to value ratio set at 50.0% (applicable to the Revolving Loans and Tranche A Loans ) and (iii) satisfy a maximum consolidated first lien leverage ratio, initially set at 2.80 :1.00, decreasing over the term of the Amended BoA Credit Agreement until reaching the final maximum ratio of 2.50 :1.00 for the fiscal quarter ended September 30, 2018 and thereafter.  The Amended BoA Credit Agreement contained certain customary events of default, including a change of control. If an event of default occurred and was not cured within any applicable grace period or not waived, the Bank of America Agent, at the request of the lenders under the Amended BoA Credit Agreement, must take various actions, including, without limitation, the acceleration of amounts due under the Amended BoA Credit Agreement.  The Company could have requested an increase in (i) the Revolving Credit Facility and Tranche A Loans, as would not have caused the consolidated first lien leverage ratio, determined on a pro forma basis after giving effect to any such increase, to exceed 2.33:1.00 and (ii) the Tranche A-1 Loans, as would not have caused the consolidated first lien leverage ratio, determined on a pro forma basis after giving effect to any such increase, to exceed (a) with respect to any increase, the proceeds of which will be used solely to finance an acquisition, 2.50 :1.00 and (b) with respect to any other increase, 2.40 :1.00, subject to the satisfaction of certain conditions in the Amended BoA Credit Agreement.  The Amended FS/KKR Credit Agreement provided for a six-year $415.0 million senior secured term loan facility. The Company could have requested one or more additional term loan facilities or the increase of term loan commitments under the Amended FS/KKR Credit Agreement as would not have caused the consolidated total leverage ratio, determined on a pro forma basis after giving effect to any such addition and increase, to have exceeded 6.00 :1.00, subject to the satisfaction of certain conditions in the Amended FS/KKR Credit Agreement.  The loans under the Amended FS/KKR Credit Agreement bore interest, at the Company’s option, at a rate equal to either (i) the LIBOR rate plus an applicable margin of 8.25% or 9.00% per annum or (ii) the base rate plus an applicable margin of 7.25% or 8.00% per annum, in each case based upon the consolidated total leverage ratio.  The Company could have made voluntary prepayments of the loans outstanding under the Amended FS/KKR Credit Agreement, subject to the payment of customary “breakage” costs with respect to LIBOR-based borrowings and, in certain cases, to the prepayment premium set forth in the Amended FS/KKR Credit Agreement. The Company was mandated to make prepayments (without payment of a premium or penalty) of loans outstanding under the Amended FS/KKR Credit Agreement amounting to: (i) where intellectual property was disposed, 50.0% of the disposed intellectual property’s orderly liquidation value, (ii) where any other asset constituting collateral is disposed or upon the receipt of certain insurance proceeds, 100% of the net proceeds thereof, subject to certain reinvestment rights, and (iii) any consolidated excess cash flow, in an amount equal to (a) in the event the consolidated total leverage ratio was at least 4.00 :1.00, 75% thereof, (b) in the event the consolidated total leverage ratio was less than 4.00 :1.00 but at least 3.00 :1.00, 50% thereof and (c) in the event the consolidated total leverage ratio was less than 3.00 :1.00, 0% thereof. On March 31, 2017 , the loans under the Amended FS/KKR Credit Agreement commenced amortization in quarterly installments, equal to 2.00% per annum of the original aggregate principal amount thereof.      The Amended FS/KKR Credit Agreement contained customary representations and warranties and customary affirmative and negative covenants applicable to the FS/KKR Facility Loan Parties and their subsidiaries. Moreover, the Amended FS/KKR Credit Agreement contained financial covenants that required the FS/KKR Facility Loan Parties and their subsidiaries to satisfy (i) a maximum consolidated total leverage ratio, initially set at 7.25 :1.00, decreasing over the term of the Amended FS/KKR Credit Agreement until reaching the final maximum ratio of 6.50 :1.00 for the fiscal quarter ended September 30, 2018 and thereafter and (ii) a maximum consolidated first lien leverage ratio, initially set at 2.80 :1.00, decreasing over the term of the Amended FS/KKR Credit Agreement until reaching the final maximum ratio of 2.50 :1.00 for the fiscal quarter ended September 30, 2018 and thereafter.  The Amended FS/KKR Credit Agreement contained certain customary events of default, including a change of control. If an event of default occurs and was not cured within any applicable grace period or was not waived, the FS/KKR Agent, at the request of the lenders under the Amended FS/KKR Credit Agreement, was required to take various actions, including, without limitation, the acceleration of amounts due thereunder.  The Company could have requested one or more additional term loan facilities or the increase of term loan commitments under the FS/KKR Credit Agreement as would not have caused the consolidated total leverage ratio, determined on a pro forma basis after giving effect to any such addition and increase, to exceed 6.00 :1.00, subject to the satisfaction of certain conditions in the FS/KKR Credit Agreement.  Interest Rate Caps  During 2016, the Company entered into interest rate cap agreements related to its 1-month LIBOR rates related to the 2016 Cap Agreements with certain financial institutions. The 2016 Cap Agreements have a $500 million notional value, strike rate of 1.50% and mature on November 23, 2018 . The Company recorded its interest rate caps on the condensed consolidated balance sheets at fair value using Level 2 inputs. The valuation technique used to determine the fair value of the 2016 Cap Agreements approximated the net present value of future cash flows, taking into account current interest rates.  The Company’s risk management objective and strategy with respect to the 2016 Cap Agreements is to reduce its exposure to variability in expected future cash outflows (forecasted interest payments) attributable to change in 1-month LIBOR rates, the designated benchmark interest rate being hedged, relating to a portion of its outstanding floating-rate debt. The 2016 Cap Agreements protect the Company from increases in hedged cash flows on its floating-rate debt attributable to changes in 1-month LIBOR rates above the strike rate. Should 1-month LIBOR rates exceed 1.50% on a rate reset date during the terms of the 2016 Cap Agreements, the financial institutions will pay the Company for an amount equivalent to the excess interest over the strike rate. To the extent the hedging relationship is perfectly effective, changes in the fair value of the hedging instrument each period will be deferred in accumulated other comprehensive income in the unaudited condensed consolidated statement of changes in equity, and the upfront hedging instrument purchase price will be reclassified to interest expense, net in the unaudited condensed consolidated statements of operations according to its caplet values. If hedge ineffectiveness exists, accumulated other comprehensive income will be adjusted to a balance that reflects the lesser of either the cumulative change in the fair value of the hedging or the cumulative change in the fair value of the hypothetically “perfect” derivative. The amount of ineffectiveness, if any, recorded in earnings would be equal to the excess of the cumulative change in the fair value of the hedging instrument over the cumulative change in the fair value of the hypothetical derivative. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2018 | |
Commitments and Contingencies [Abstract] | |
Commitments and Contingencies |   8. Commitments and Contingencies General Legal Matters From time to time, the Company is involved in legal matters arising in the ordinary course of business. While the Company believes that such matters are currently not material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations. Contingent liabilities arising from potential litigation are assessed by management based on the individual analysis of these proceedings and on the opinion of the Company’s lawyers and legal consultants.           |
Stock-based Compensation
Stock-based Compensation | 9 Months Ended |
Sep. 30, 2018 | |
Stock-based Compensation [Abstract] | |
Stock-based Compensation |    9. Stock-based Compensation Stock Options  The following table summarizes the Company’s stock option activity for the nine months ended September 30, 2018 :   Number of Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (in Years) Aggregate Intrinsic Value   (in thousands, except share and per share data)   Outstanding - January 1, 2018 84,001 $ 8.65 2.1 $ -  Granted - -  Exercised - -  Forfeited or canceled (26,500) (6.59)  Outstanding at September 30, 2018 57,501 $ 9.61 2.2 $ -   Exercisable - September 30, 2018 57,501 $ 9.61 2.2 $ - The Company did not grant any stock options during the three and nine months ended September 30, 2018 and 2017 .  There was no compensation expense related to s tock options for the three and nine months end ed September 30, 2018. Total compensation expense related to stock opti ons for each of the three and nine months ended September 30, 2017 was less than $0.1 million. At September 30, 2018 there is no unrecognized compensation expense related to stock options and no unvested stock options.  Warrants  The following table summarizes the Company’s outstanding warrants for the nine months ended September 30, 2018 :   Number of Warrants Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (in Years) Aggregate Intrinsic Value   (in thousands, except share and per share data)   Outstanding - January 1, 2018 770,160 $ 7.95 2.2 $ -  Granted - -  Exercised - -  Forfeited or canceled (560,160) (6.09)  Outstanding at September 30, 2018 210,000 $ 12.94 6.4 $ -   Exercisable - September 30, 2018 210,000 $ 12.94 6.4 $ -  The Company did not issue any warrants during the three and nine months ended September 30, 2018 and 2017 .  There was no compensation expense related to warrants for the three and nine months ended September 30, 2018. Total compensation expense related to warrants for each of the three and nine months ended September 30, 2017 was less than $0.1 million. At September 30, 2018 , there is no unrecognized compensation expense related to warrants and no unvested warrants .        Restricted Stock  A summary of the time-based restricted stock activity for the nine months ended September 30, 2018 is as follows:    Number of Shares Weighted-Average Grant Date Fair Value Weighted-Average Remaining Contractual Life (in Years)   (in thousands, except share and per share data)   Unvested - January 1, 2018 195,536 $ 7.23 1.8  Granted 235,296 1.70  Vested (118,612) (4.17)  Unvested - September 30, 2018 312,220 $ 4.23 1.2  During the nine months ended September 30, 2018, the Company granted 235,296 shares of time-based restricted stock to members of the Company’s board of directors. These shares had a grant date fair value of $0.4 million and vest over a period of one year. The Company recorded $0.1 million and $0.2 million during th e three and nine months ended September 30, 2018 , respectively, as compensation expense pertaining to these grants.  Du ring the nine months ended September 30, 2017, the Company granted 111,112 shares of time-based restricted stock to members of the Company’s board of directors. These shares had a grant date fair value of $0.4 million and vest over a period of one year. The Company recorded $0.1 million during the nine months ended September 3 0, 2018 as compensation expense pertaining to these grants. The Company recorded $0.1 million and $0.2 million during the three and nine months ended September 30, 2017 as compensation expense pertaining to these grants.  Total compensation expense related to time-based restricted stock grants for the three months ended September 30, 2018 and 2017 was $0.1 million and $0.1 million, respectively. Total compensation expense related to time-based r estricted stock grants for the nine months ended September 30, 2018 and 2017 was $0.4 million and $0.5 million, respectively. Total unrecognized compensation expense related to time-based restricted stock grants at September 30, 2018 amounted to $0.3 million and is expected to be recognized over a weighted-average period of 1.2 years.  Restricted Stock Units  A summary of the time-based restricted stock units activity for the nine months ended September 30, 2018 is as follows:    Number of Shares Weighted-Average Grant Date Fair Value Weighted-Average Remaining Contractual Life (in Years)   (in thousands, except share and per share data)   Unvested - January 1, 2018 736,400 $ 3.89 2.2  Granted 2,478,743 1.81  Vested (1,696,127) (2.17)  Forfeited or canceled (16,667) (7.61)  Unvested - September 30, 2018 1,502,349 $ 2.35 2.3  During the three and nine months ended September 30, 2018, the Company granted 325,000 and 1,635,257 time-based restricted stock units, respectively, to certain employees and consultants for future services. These shares of time-based restricted stock units had a grant date fair value of $0.7 million and $3.0 million, respectively, and vest immediately to over a period of five years. The Company recorded $0.8 million and $1.5 million during the three and nine months ended September 30, 2018, respectively, as compensation expense pertaining to these grants.  During the nine months ended September 30, 2018, the Company issued 843,486 time-based restricted stock units to an employee for a 2017 performance-based bonus pursuant to their employment agreement. The bonus was paid in restricted stock in the first quarter of 2018, based on the average closing stock price for the 30 days preceding March 1, 2018. Compensation expense was fully recognized in 2017 related to this grant.  During the three and nine months ended September 30, 2017, the Company granted 200,000 time-based restricted stock units to certain employees for future services and 276,753 time-based restricted stock units to a consultant for future services. These shares of time-based restricted stock units had a grant date fair value of $1.4 million and vest over a period of three years. The Company recorded $0.1 million and less than $0.1 million during the three months ended September 30, 2018 and 2017, respectively, as compensation expense pertaining to these grants. The Company recorded $0.3 million and less than $0.1 million during the nine months ended September 30, 2018 and 2017, respectively, as compensation expense pertaining to these grants.  During the nine months ended September 30, 2017 , the Company granted 100,000 time-based restricted stock units to the Company’s Chief Executive Officer pursuant to an employment agreement, dated April 3, 2017. These shares of time-based restricted stock units had a grant date fair value of $0.4 million and vest over a period of three years. The Company recorded less than $0.1 million during the each of the three months ended September 30, 2018 and 2017 as compensation expense pertaining to this grant. The Company recorded $0.1 million and less than $0.1 million during the nine months ended September 30, 2018 and 2017 , respectively, as compensation expense pertaining to this grant.  During the nine months ended September 30, 2017, the Company accelerated the vesting of 66,667 shares of time-based restricted stock units for the Company’s former Chief Executive Officer in connection with the CEO transition. Total compensation expense related to these shares of $0.7 million was recorded as operating expenses in the unaudited condensed consolidated st atement of operations for the nine months ended September 30, 2017.  During the nine months ended September 30, 2017, the Company granted 60,000 time-based restricted stock units to the Company’s former Chief Financial Officer pursuant to an amended employment agreement, dated January 3, 2017. These shares of time-based restricted stock units had a grant date fair value of $0.3 million and a vesting period of two years. Upon the former Chief Financial Officer’s departure, these shares were forfeited prior to vesting during the three months ended September 3 0 , 2017. Compensation expense previously recogni zed was reversed during the three and nine months ended Septemb er 3 0 , 2017.  Total compensation expense related to time-based restricted stock unit grants for the three months ended September 30, 2018 and 2017 was $1.1 million and $0.2 million, respectively. Total compensation expense related to time-based restricted stoc k unit grants for the nine months ended September 30, 2018 and 2017 was $2.2 million and $1.4 mi llion , respectively . Total unrecognized compensation expense related to time-based restricted stock unit grants at September 30, 2018 amounted to $2.7 million and is expected to be recognized over a weighted-average period of 2.3 years.  Performance Stock Units A summary of the PSUs activity for the nine months ended September 30, 2018 is as follows:    Number of Shares Weighted-Average Grant Date Fair Value Weighted-Average Remaining Contractual Life (in Years)   (in thousands, except share and per share data)   Unvested - January 1, 2018 2,045,634 $ 5.83 2.0  Granted 785,000 1.98  Vested (350,408) (4.71)  Forfeited or canceled (255,697) (7.32)  Unvested - September 30, 2018 2,224,529 $ 4.48 1.0  During the three months ended September 30, 2018, the Company granted 135,000 PSUs to employee s pursuant to their employment agreement s . These PSUs had a grant date fair value of $0.3 million, vest over a period of one to two years and require achievement of certain performance metrics within each fiscal year for such PSUs to be earned. The Company issued 83,250 PSUs to an employee related to this grant. The fair value and exp ense recorded for such PSUs was based on the closing price of the Company ’s common stock on the date the performance metric was communicated to the employee . The Company recorded $0.2 million in compensation expense during the three months ended September 30, 2018 as operating expenses in the unaudited condensed consolidated statements of operations .    During the nine months ended September 30, 2018, the Company granted 200,000 PSUs to an employee upon their commencement of employment with the Company. These PSUs had a grant date fair value of $0.4 million, vest over a period of three years and require achievement of certain of the Company’s performance metrics within each fiscal year for such PSUs to be earned. The Company did not record any compensati on expense during the nine months ended September 30, 2018 as the likelihood of these PSUs being earned was not considered probable.  During the nine months ended September 30, 2018, the Company granted 200,000 PSUs to an employee upon their commencement of employment with the Company. These PSUs had a grant date fair value of $0.5 million, vest over a period of two years and require achievement of certain of the Company’s performance metrics within each fiscal year for such PSUs to be earned. The Company did not record any compensati on expense during the nine months ended September 30, 2018 as the likelihood of these PSUs being earned was not considered probable.  During the nine mon ths ended September 30, 2018, the Company granted 250,000 PSUs to a consultant pursuant to their endorsement agreement. The PSUs had a grant date fair value of $0.5 million, vest over a period of five years and require achievement of certain sales targets within each fiscal year for such PSUs to be earned. The Company did not record any compensati on expense during the nine months ended September 30, 2018 as the likelihood of these PSUs being earned was not considered probable.  On February 20, 2018, the Compensation Committee voted to approve, on a discretionary basis, vesting of 208,883 PSUs to employees and consultants previously granted during the years ended December 31, 2016 and 2017 subject to achievement of certain of the Company’s performance metrics within each fiscal year. The fair value and expense recorded for such PSUs was based on the closing price of the Company’s common stock on the date the modification of the performance metric was communicated to employees and consultants. Total compensation expense related to these PSUs of $0.5 million was recorded as operating expenses in the unaudited condensed consolidated sta tements of operations for the nine months ended September 30, 2018.  During the three months ended September 30, 2017, the Company granted 200,000 PSUs to an employee upon their commencement of employment with the Company. These PSUs had a grant date fair value of $0.7 million and vest over a period of three years and require achievement of certain of the Company’s performance metrics within each fiscal year for such PSUs to be earned. The Company recorded expense related to this award for the nine months ended September 30, 2018 as part of the discretionary vesting approved by the Compensation Committee on February 20, 2018. No additional expense was recorded during the three and nine months ended September 30, 2018 as the likelihood of these PSUs being earned was not probable. The Company did not record any compensation expense during the three and nine months ended September 30, 2017 as the likelihood of these PSUs being earned was not probable.  During the three months ended September 30, 2017, the Company granted 41,600 PSUs to employees and consultants. The PSUs had a grant date fair value of $0.1 million and vest over a period of three years and require achievement of certain of the Company’s performance metrics within each fiscal year for such PSUs to be earned. The Company recorded expense related to this award for the nine months ended September 30, 2018 as part of the discretionary vesting approved by the Compensation Committee on February 20, 2018. No additional expense was recorded during the three and nine months ended September 30, 2018 as the likelihood of these PSUs being earned was not probable. The Company did not record any compensation expense during the three and nine months ended September 30, 2017 as the likelihood of these PSUs being earned was not probable.  During the three months ended September 30, 2017, the Company granted 300,000 PSUs to the Company’s Chief Executive Officer. These PSUs had a grant date fair value of $0.8 million and vest over a period of three years and require achievement of certain of the Company’s performance metrics within each fiscal year for such PSUs to be earned. The Company recorded expense related to this award for the nine months ended September 30, 2018 as part of the discretionary vesting approved by the Compensation Committee on February 20, 2018. No additional expense was recorded during the three and nine months ended September 30, 2018 as the likelihood of these PSUs being earned was not probable. The Company did not record any compensation expense during the three and nine months ended September 30, 2017 as the likelihood of these PSUs being earned was not probable.  During the nine months ended September 30, 2017, the Company granted 175,000 PSUs to the Company’s Chief Executive Officer pursuant to an employment agreement, dated April 3, 2017. These PSUs had a grant date fair value of $0.7 million, vest over a period of three years and require achievement of certain of the Company’s performance metrics within each fiscal year for such PSUs to be earned. The Company recorded $0.2 million in co mpensation expense during the nine months ended September 30, 2018 as the performance metrics were achieved pursuant to fiscal year end results. The Company recorded less than $0.1 million and $0.1 million in compensation expens e during the three and nine months ended September 30, 2018 , respectively, as the likelihood of these PSUs being earned was considered probable for the current fiscal year.  During the nine months ended September 30, 2017, the Company accelerated the vesting of 200,000 PSUs for the Company’s former Chief Executive Officer in connection with the CEO transition. Total compensation expense related to these PSUs of $2.9 million was recorded as operating expenses in the unaudited condensed consolidated st atement of operations for the nine months ended September 30, 2017.  On Feb ruary 28, 2017, the Compensation Committee voted to approve, on a discretionary basis, an award of 164,978 PSUs to employees and consultants. Included in the above award were 60,000 PSUs and 36,000 PSUs for the Company’s former Chief Executive Officer and Chief Financial Officer, respectively. The fair value and expense recorded for such PSUs were based on the closing price of the Company’s common stock on the date the modification of the performance metric was communicated to employees and consultants. Total compensation expense related to these PSUs of $0.6 million was recorded as operating expenses in the unaudited condensed consolidated statements of operations for the nine months ended September 30, 2017.  Total compensation expense related to the PSU s for the three months ended September 30, 2018 was $0.2 million. The Company did not record compensation expense related to the P SUs for the three months ended September 30, 2017. Total compensation expens e related to the PSUs for the nine months ended September 30, 2018 and 2017 was $0.9 million and $3.5 million, respectively . |
Related Party Transactions
Related Party Transactions | 9 Months Ended |
Sep. 30, 2018 | |
Related Party Transactions [Abstract] | |
Related Party Transactions |   10. Related Party Transactions  Consulting Services Agreement with Tengram Capital Partners, L.P. (f/k/a Tengram Capital Management L.P.)  Pursuant to an agreement with Tengram Capital Partners, L.P., formerly known as Tengram Capital Management, L.P. (“TCP”), an affiliate of Tengram Capital Partners Gen2 Fund, L.P., which is one of the Company’s largest stockholders, the Company has engaged TCP, effective as of January 1, 2013, to provide services to the Company pertaining to (i) mergers and acquisitions, (ii) debt and equity financing and (iii) such other related areas as the Company may reasonably request from time to time (the “TCP Agreement”). The TCP Agreement remains in effect for a period continuing through the earlier of five years or the date on which TCP and its affiliates cease to own in excess of 5% of the outstanding shares of common stock in the Company. On August 15, 2014, the Company consummated transactions pursuant to an agreement and plan of merger, dated as of June 24, 2014 (the “Galaxy Merger Agreement”) with SBG Universe Brands LLC, a Delaware limited liability company and the Company’s direct wholly-owned subsidiary (“LLC Sub”), Universe Galaxy Merger Sub, Inc., a Delaware corporation and direct wholly-owned subsidiary of LLC Sub, Galaxy Brand Holdings, Inc. and Carlyle Galaxy Holdings, L.P. (such transactions, collectively, the “Galaxy Acquisition”). In connection with the Galaxy Merger Agreement, the Company and TCP entered into an amendment to the TCP Agreement (the “Amended TCP Agreement”), pursuant to which, among other things, TCP is entitled to receive annual fees of $0.9 million beginning with fiscal 2014.  The Company paid TCP $0.2 million for services under the Amended TCP Agreement during the three months ended September 30, 2018. The Company paid TCP $0.7 million and $0.5 million for services under the Amended TCP Agreement during the nine months ended September 30, 2018 and 2017, respectively . At September 30, 2018 and December 31, 2017 , there were no amounts due to TCP for services.  Additionally, in July 2013, the Company entered into a consulting arrangement with an employee of TCP (the “TCP Employee”), pursuant to which the TCP Employee provides legal and other consulting services at the request of the Company from time to time. The TCP Employee was also issued 125,000 shares of restricted stock, vesting over a four -year period and 180,000 PSUs, vesting over three years in increments of 20% for 2014 , 20% for 2015 and 60% for 2016 . In 2016, the TCP employee was granted 200,000 PSUs, vesting over three years in increments of 33.3% for 2017 , 33.3% for 2018 and 33.4% for 2019. In 2018, the TCP employee was granted 150,000 shares of time-based restricted stock units, vesting over a three year period and 300,000 shares of time-based restricted stock units, vesting over a three year period with 25% vesting immediately. The Company paid the TCP Employee $0.1 million for services under the consulting arrangement during each of the three-month periods ended September 30, 2018 and 2017. The Company paid the TCP Employee $0.2 million for services under the consulting arrangement during each of the nine-month periods ended September 30, 2018 and 2017 . These amounts are included in operating expenses in the Company’s unaudited condensed consolidated financial statements. At September 30, 2018 and December 31, 2017 , less than $0.1 million was due to the TCP Employee.  Transactions with Tommie Copper, Inc.  The Company entered into an agreement with Tommie Copper, Inc. (“TCI”), an affiliate of TCP, under which the Company received a vendor placement fee for facilitating certain distribution arrangements. The Company recorded $3.1 million of revenue for the nine months ended September 30, 2018. During the three month period ended September 30, 2018, the Company recorded non-cash interest income of less than $0.1 million related to the accretion of the present value of this fee. At September 30, 2018, the Company recorded a current receivable of $1.0 million from TCI in other current assets and a long-term receivable of $2.1 million from TCI in other assets in the condensed consolidated balance sheets.       Transactions with E.S. Originals, Inc.  A division president of the Company maintains a passive ownership interest in one of the Company’s licensees, E.S. Originals, Inc. (“ESO”). The Company receives royalties from ESO under license agreements for certain of the Company’s brands in the footwear category. The Company recorded $1.1 million and $3.5 million of revenue for the three months ended September 30, 2018 and 2017 , respectively, for royalties, commission, and advertising revenue earned from ESO license agreements. The Company recorded $3.8 million and $11.3 million of revenue for the nine months ended September 30, 2018 and 2017, respectively, for royalties, commission, and advertising revenue earned from ESO license agreements. At September 30, 2018 and December 31, 2017 , the Company had $4.9 million and $7.2 million recorded as accounts receivable from ESO in the condensed consolidated balance sheets, respectively.  The Company entered into an agreement with ESO under which the Company received a sales commission . The Company recorded $1.9 million and $2.8 million of revenue for the three and nine months ended September 30, 2018, respectively. At September 30, 2018, the Company had $1.0 million recorded as accounts receivable from ESO and $1.3 million recorded as other assets in the condensed consolidated balance sheets.  In addition, the Company entered into a license-back agreement with ESO under which the Company reacquired the rights to certain international territories in order to re-license these rights to an unrelated party. The Company recorded less than $0.1 million and $0.2 million in license-back expense for the three and nine months ended September 30, 2018, respectively.  Acquisition of FUL  On November 17, 2014, the Company made a strategic investment in FUL IP. FUL IP is a collaborative investment between the Company and JALP. FUL IP was formed for the purpose of licensing the FUL trademark to third parties in connection with the manufacturing, distribution, marketing and sale of FUL branded bags, backpacks, duffels, luggage and apparel accessories. JALP contributed the FUL trademark with a fair value of $8.9 million. In exchange for a 50.5% economic interest in FUL IP, the Company paid JALP $4.5 million. JALP’s minority member interest in FUL IP has been reflected as noncontrolling interest on the Company’s condensed consolidated balance sheets. One of the Company’s directors, Mr. Al Gossett, has a partial ownership interest in JALP. During the nine months ended September 30, 2018, the Company sold the FUL trademark and incurred a loss on the sale of the trademark of $2.0 million. No noncontrolling interest was recorded during the three months ended September 30, 2018. There was $(0.7) million of noncontrolling interest loss recorded during the nine months ended September 30, 2018. There was $(2.4) million of noncontrolling interest loss recorded during the three and nine months ended September 30, 2017 .  Investment in Available-for-Sale Securities  In September 2015, the Company purchased available-for-sale securities of an unaffiliated third-party publicly traded company from Tengram Capital Partners, L.P., which is an affiliate of Tengram Capital Partners Gen2 Fund, L.P., one of the Company’s largest stockholders, for an aggregate purchase price of $12.0 million (plus related transaction expenses), which was the purchase price paid by Tengram Capital Partners, L.P. upon the acquisition of such available-for-sale securities in open market transactions. The Company did not pay a fee or any compensation to Tengram Capital Partners, L.P. in connection with the Company’s investment in the available-for-sale securities. During the nine months ended September 30, 2017, the Company sold its available-for-sale securities for $5.8 million.  IP License Agreement and Intangible Asset Agreement  In connection with the transactions contemplated by the acquisition of MSLO (the “Mergers”), MSLO entered into an Amended and Restated Asset License Agreement (“Intangible Asset Agreement”) and Amended and Restated Intellectual Property License and Preservation Agreement (“IP License Agreement” and, together with the Intangible Asset Agreement, the “IP Agreements”) pursuant to which Ms. Martha Stewart licensed certain intellectual property to MSLO. The IP Agreements grant the Company the right to use of certain properties owned by Ms. Stewart.  The Intangible Asset Agreement has an initial term commencing at December 4, 2015 and ending on December 31, 2020, provided that the term will automatically be renewed for five additional calendar years ending December 31, 2025 (subject to earlier termination as provided in Ms. Stewart’s employment agreement) if either the aggregate gross licensing revenues (as defined in Ms. Stewart’s employment agreement) for calendar years 2018 through 2020 exceed $195 million or the gross licensing revenues for calendar year 2020 equal or exceed $65 million. During the term of the Intangible Asset Agreement with the Company, Lifestyle Research Center LLC will be entitled to receive a guaranteed annual payment of $1.7 million, which amounts are being paid in connection with the Mergers regardless of Ms. Stewart’s continued employment with the Company plus reimbursable expenses. The Company has paid Lifestyle Research Center LLC less than $0.1 million and $0.8 million in connection with other related services during the three months ended September 30, 2018 and 2017, respectively . The Company has paid Lifestyle Research Center LLC $0.3 million and $1.4 million in connection with other related services during the nine months ended September 30, 2018 and 2017, respectively.  During the term of the IP License Agreement with the Company, Ms. Stewart will be entitled to receive a guaranteed annual payment of $1.3 million , which amounts are being paid in connection with the Mergers regardless of Ms. Stewart’s continued employment with the Company. During each of the three months ended September 30, 2018 and 2017 , the Company made payments of $0.3 million to Ms. Stewart in connection with the terms of the IP License Agreement. During each of the nine months ended September 30, 2018 and 2017, the Company made payments of $1.0 million to Ms. Stewart in connection with the terms of the IP License Agreement. The IP License Agreement is perpetual. During the three month periods ended September 30, 2018 and 2017 , the Company expensed non-cash interest of $0.1 million and $0.2 million, respectively, related to the accretion of the present value of these guaranteed contractual payments. During the nine month periods ended September 30, 2018 and 2017, the Company expensed non-cash interest of $0.3 million and $0.5 million, respectively, related to the accretion of the present value of these guaranteed contractual payments. At September 30, 2018 , there was $5.8 million due under the IP Agreements of which $2.9 million is recorded in accounts payable and accrued expenses and $2.9 million is recorded in other long-term liabilities. At December 31, 2017 , there was $6.4 million due under the IP Agreements of which $2.8 million is recorded in accounts payable and accrued expenses and $3.6 million is recorded in other long-term liabilities. During the three months ended September 30, 2018, Ms. Stewart was awarded a one-time bonus of 300,000 shares of time-based restricted stock units. These shares of time-based restricted stock units had a grant date fair value of $0.6 million and vested immediately. The Company recorded $0.6 million during the three months ended September 30, 2018 as compensation expense pertaining to this grants . |
New Accounting Pronouncements
New Accounting Pronouncements | 9 Months Ended |
Sep. 30, 2018 | |
New Accounting Pronouncements [Abstract] | |
New Accounting Pronouncements |   11. New Accounting Pronouncements  ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement”  In August 2018, the FASB issued ASU No. 2018-13 “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement” (“ASU 2018-13”). ASU 2018-13 eliminates, amends, and adds certain disclosure requirements for fair value measurements.  ASU 2018-13 is effective for annual and interim periods beginning after December 15, 2019, and early adoption is permitted for the entire standard or for the provisions that eliminate or amend disclosure requirements. The Company does not expect the adoption of ASU 2018-13 to have a material impact on the Company’s condensed consolidated financial statements.  ASU No. 2018-07, “Improvements to Nonemployee Share-Based Payment Accounting”  In June 2018, the FASB issued ASU No. 2018-07 “Improvements to Nonemployee Share-Based Payment Accounting” (“ASU 2018-07”). ASU 2018-07 aligns the accounting for share-based payment awards to employees and non-employees. Under ASU 2018-07 the existing employee guidance will apply to nonemployee share-based transactions, except for specific guidance related to the attribution of compensation cost. ASU 2018-07 should be applied to all new awards granted after the date of adoption.  ASU 2018-07 is effective for annual and interim periods beginning after December 15, 2018, and early adoption is permitted. The Company does not expect the adoption of ASU 2018-02 to have a material impact on the Company’s condensed consolidated financial statements.  ASU No. 2018-02, “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income”  In February 2018, the FASB issued ASU No. 2018-02, “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income” (“ASU 2018-02”). ASU 2018-02 permits a company to reclassify the disproportionate income tax effects (“stranded tax effects”) of the Tax Cuts and Jobs Act of 2017 on items within accumulated other comprehensive income to retained earnings.  ASU 2018-02 is effective for annual and interim periods beginning after December 15, 2018, and early adoption is permitted. The Company does not expect the adoption of ASU 2018-02 to have a material impact on the Company’s condensed consolidated financial statements.  ASU No. 2017-12, “Targeted Improvements to Accounting for Hedging Activities”  In August 2017, the FASB issued ASU No. 2017-12, “Targeted Improvements to Accounting for Hedging Activities” (“ASU 2017-12”). ASU 2017-12 amends the hedge accounting recognition and presentation requirements in ASC 815, Derivatives and Hedging . The amendments in ASU 2017-12 are intended to improve the transparency and understandability of information about an entity’s risk management activities and simplify the application of hedge accounting.  ASU 2017-12 is effective for annual and interim periods beginning after December 15, 2018, and early adoption is permitted. The Company does not expect the adoption of ASU 2017-12 to have a material impact on the Company’s condensed consolidated financial statements.  ASU No. 2016-02, “Leases” In February 2016, the FASB issued ASU No. 2016-02, “Leases” (“ASU 2016-02”). The core principle of ASU 2016-02 is that an entity should recognize on its balance sheet assets and liabilities arising from a lease. In accordance with that principle, ASU 2016-02 requires that a lessee recognize a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying leased asset for the lease term. The recognition, measurement, and presentation of expenses and cash flows arising from a lease by a lessee will depend on the lease classification as a finance or operating lease. In July 2018, the FASB issued ASU No. 2018-10, “Codification Improvements to Topic 842, Leases” (“ASU 2018-10”) and ASU No. 2018-11, “Leases (Topic 842): Targeted Improvements” (“ASU 2018-11”) to improve certain aspects of ASU 2016-02.  ASU 2016-02 is effective for annual and interim periods beginning after December 15, 2018, and early adoption is permitted. The Company plans to adopt the new standard on its effective date of January 1, 2019. The Company plans to elect the package of practical expedients upon transition where the Company will not reassess the lease classification and initial direct costs for leases that existed prior to adoption. Additionally, the Company will not reassess contracts entered into prior to adoption to determine whether the arrangement is or contains a lease. The Company anticipates the adoption of the standard will increase assets and liabilities on its condensed consolidated balance sheets primarily related to its corporate headquarters lease and will not have a material impact on the Company’s condensed consolidated financial statements.                                |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2018 | |
Summary of Significant Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and footnotes necessary for a comprehensive presentation of financial position, results of operations or cash flows. It is the Company’s opinion, however, that the accompanying unaudited condensed consolidated financial statements include all adjustments, which are of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 , as filed with the SEC on March 16, 2018, which contains the audited consolidated financial statements and notes thereto, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations, for the years ended December 31, 2017, 2016 and 2015. The financial information as of December 31, 2017 is derived from the audited consolidated financial statements presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017 . The interim results for the nine months ended September 30, 2018 are not necessarily indicative of the results to be expected for the year ending December 31, 2018 or for any future interim periods. |
Reclassification of Prior Year Presentation | Reclassification of Prior Year Presentation  On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2016-18 “Statement of Cash Flows (Topic 230): Restricted Cash” (“ASU 2016-18”), which changes the presentation of restricted cash on the statement of cash flows. ASU 2016-18 requires an entity to show the changes in total cash, cash equivalents, restricted cash, and restricted cash equivalents in the statement of cash flows.  As a result of the adoption of ASU 2016-18, the Company no longer shows the changes in restricted cash on the statement of cash flows and reconciles to the total cash and restricted cash balance, which are presented separately on the condensed consolidated balance sheets. |
Principles of Consolidation | Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. |
Use of Estimates | Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.  Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates. |
Revenue Recognition | Revenue Recognition The Company recognizes revenue in accordance with ASC 606, “Revenue from Contracts with Customers” (“ASC 606”), which became effective for the Company as of January 1, 2018 (See Note 4 for impact of adoption and other related disclosures). ASC 606 requires a five-step approach to determine the appropriate method of revenue recognition for each contractual arrangement:  Step 1: Identify the Contract(s) with a Customer Step 2: Identify the Performance Obligation(s) in the Contract Step 3: Determine the Transaction Price Step 4: Allocate the Transaction Price to the Performance Obligation(s) in the Contract Step 5: Recognize Revenue when (or as) the Entity Satisfies a Performance Obligation  The Company has entered into various license agreements for its owned trademarks. Under ASC 606, the Company’s agreements are generally considered symbolic licenses, which contain the characteristics of a right-to-access license since the customer is simultaneously receiving the intellectual property (“IP”) and benefiting from it throughout the license period. The Company assesses each license agreement at inception and determines the performance obligation(s) and appropriate revenue recognition method. As part of this process, the Company applies judgments based on historical trends when estimating future revenues and the period over which to recognize revenue. The Company generally recognizes revenue for license agreements under the following methods: 1. Licenses with guaranteed minimum royalties (“GMRs”): Generally, guaranteed minimum royalty payments (fixed revenue) are recognized on a straight-line basis over the term of the contract, as defined in each license agreement. 2. Licenses with both GMRs (fixed revenue) and earned royalties (variable revenue): Earned royalties in excess of fixed revenue are only recognized when the Company is reasonably certain that the guaranteed minimum payments for the period, as defined in each license agreement, will be exceeded. Additionally, the Company has categorized certain contracts as variable when there is a history and future expectation of exceeding GMRs. The Company recognizes income for these contracts during the period corresponding to the licensee’s sales. 3. Licenses that are sales-based only or earned royalties: Earned royalties (variable revenue) are recognized as income during the period corresponding to the licensee’s sales.  Payments received as consideration for the grant of a license or advanced royalty payments are recorded as deferred revenue at the time payment is received and recognized into revenue under the methods described above.  Contract assets represent unbilled receivables and are presented within accounts receivable, net on the condensed consolidated balance sheets. Contract liabilities represent unearned revenues and are presented within the current portion of deferred revenue on the condensed consolidated balance sheets.  The Company disaggregates its revenue into two categories: licensing agreements and other, which is comprised of revenue from sources such as editorial content for book s, television sponsorships, sales commissions and vendor placement commissions .  With respect to editorial content for books, the Company receives advance payments from the Company’s publishers and recognizes revenue when manuscripts are delivered to and accepted by the publishers. Revenue is also earned from book publishing when sales on a unit basis exceed the advanced royalty. Television sponsorship revenues are generally recorded ratably across the period when new episodes initially air. Revenue from media content is recognized at a point in time, when the content is delivered and accepted.  Commission revenues and vendor placement commission revenues are recorded in the period the commission is earned.  The Company entered into a transaction with a media company for which it receives advertising credits as part of the consideration exchanged. These transactions are recorded at the estimated fair value of the advertising credits received, as their fair value is deemed more readily determinable than the fair value of the trademark licensing right provided by the Company, in accordance with ASC 845, Nonmonetary Transactions . The fair value of the advertising credits are recorded as revenue and in other assets when earned, and expensed when the advertising credits are utilized. The Company recorded $1.2 million and $1.6 million of revenue for the three and nine months ended September 30, 2018 related to the advertising credits. The Company recorded revenue of $0.8 million for the three and nine months ended September 30, 201 7 related to the advertising credits. The Company recorded $0.6 million and $0.8 million of expense related to the advertising credits utilized for the three and nine months ended September 30, 2018. |
Restricted Cash |  Restricted Cash  Restricted cash consists of cash deposited with a financial institution required as collateral for the Company’s cash-collateralized letter of credit facilities. |
Accounts Receivable | Accounts Receivable Accounts receivable are recorded net of allowances for doubtful accounts, based on the Company’s ongoing discussions with its licensees and other customers and its evaluation of their creditworthiness, payment history and account aging. Accounts receivable balances deemed to be uncollectible are written off after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $0.5 million and $ 0.6 million as of September 30, 2018 and December 31, 2017, respectively .  The Company’s accounts receivable, net amounted to $63. 5 million and $60.1 million as of September 30, 2018 and December 31, 2017 , respectively. Three licensees accounted for approximately 43% ( 21% , 12% , and 10% ) of the Company’s total consolidated accounts receivable balance as of September 30, 2018 and three licensees accounted for approximately 53% ( 25% , 15% and 13% ) of the Company’s total consolidated accounts receivable balance as of December 31, 2017 . The Company does not believe the accounts receivable balance from these licensees represents a significant collection risk based on past collection experience. |
Investments |  Investments The Company had marketable securities that were classified as available-for-sale securities under ASC 320, Investments – Debt and Equity Securities . Such available-for-sale securities are reported at fair value in the condensed consolidated balance sheets and, at the time of purchase, were reported in the unaudited condensed consolidated statements of cash flows as an investing activity. The Company reviewed its available-for-sale securities at each reporting period to determine whether a decline in fair value is other-than-temporary. Any decline in fair value that was determined to be other-than-temporary would result in an adjustment for an impairment charge in the accompanying unaudited condensed consolidated statements of operations. The primary factors the Company considers in its determination are (i) the length of time that the fair value of the available-for-sale security is below the Company’s carrying value, (ii) the financial condition and operating performance of the available-for-sale security, (iii) the reason for decline in fair value and (iv) the Company’s intent and ability to hold the investment in available-for-sale security for a period of time sufficient to allow for a recovery in fair value. Realized gains and losses from the sale of available-for-sale securities, if any, are determined on a specific-identification basis. The Company did not hold any material investments at September 30, 2018 or December 31, 2017. |
Equity Method Investment | Equity Method Investment  For investments in entities over which the Company exercises significant influence but which do not meet the requirements for consolidation, the Company uses the equity method of accounting. On July 1, 2016, the Company acquired a 49.9% noncontrolling interest in Gaiam Pty. Ltd. in connection with its acquisition of Gaiam Brand Holdco, LLC, which is included in other assets in the condensed consolidated balance sheets. The Company’s share of earnings from its equity method investee, which was not material for the three and nine months ended September 30, 2018 and 2017, is included in other income in the unaudited condensed consolidated statements of operations.  The Company evaluates its equity method investment for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investment may not be recoverable. The difference between the carrying value of the equity method investment and its estimated fair value is recognized as an impairment charge when the loss in value is deemed other-than-temporary. |
Goodwill and Intangible Assets | Goodwill and Intangible Assets Goodwill represents the excess of purchase price over the fair value of net assets acquired in business combinations accounted for under the purchase method of accounting. The Company does not have any goodwill reported on its consolidated balance sheets at September 30, 2018 and December 31, 2017.  On an annual basis (October 1 st ) and as needed, the Company tests goodwill and indefinite lived trademarks for impairment through the use of discounted cash flow models. Assumptions used in our discounted cash flow models are as follows: (i) discount rates; (ii) projected average revenue growth rates; and (iii) projected long-term growth rates. Our estimates also factor in economic conditions and expectations of management, which may change in the future based on period-specific facts and circumstances. Other intangibles with determinable lives, including certain trademarks, customer agreements, patents and a favorable lease, are evaluated for the possibility of impairment when certain indicators are present, and are otherwise amortized on a straight-line basis over the estimated useful lives of the assets (currently ranging from 2 to 15 years).  During the quarter ended September 30, 2018, the Company recorded non-cash impairment charges of $17.9 million for indefinite-lived intangible assets related to the trademarks of two of the Company’s non-core brands: Caribbean Joe and Ellen Tracy. The impairments arose due to reduced growth expectations and the impact of licensee transitions for these brands. During the quarter ended September 30, 2017, the Company recorded non-cash impairment charges of $36.5 million for indefinite-lived intangible assets related to the trademarks of five of the Company’s non-core brands: Caribbean Joe, Revo, Franklin Mint, Nevados, and FUL. The impairments arose due to reduced contractual minimums or reduced sales forecasts in key distribution channels for these brands. Fair value for each trademark was determined based on the income approach using estimates of future discounted cash flows. These charges are included in impairment charges in the unaudited condensed consolidated statements of operations. See Note 3 and Note 6 for further information. |
Treasury Stock | Treasury Stock  Treasury stock is recorded at cost as a reduction of equity in the condensed consolidated balance sheets. |
Stock-Based Compensation | Stock-Based Compensation  Compensation cost for restricted stock is measured using the quoted market price of the Company’s common stock at the date the common stock is granted. For restricted stock and restricted stock units, for which restrictions lapse with the passage of time (“time-based restricted stock”), compensation cost is recognized on a straight-line basis over the period between the issue date and the date that restrictions lapse. Time-based restricted stock is included in total shares of common stock outstanding upon the lapse of applicable restrictions. For restricted stock, for which restrictions are based on performance measures (“performance stock units” or “PSUs”), restrictions lapse when those performance measures have been deemed achieved. Compensation cost for PSUs is recognized on a straight-line basis during the period from the date on which the likelihood of the PSUs being earned is deemed probable and (x) the end of the fiscal year during which such PSUs are expected to vest or (y) the date on which awards of such PSUs may be approved by the compensation committee of the Company’s board of directors (the “Compensation Committee”) on a discretionary basis, as applicable. PSUs are included in total shares of common stock outstanding upon the lapse of applicable restrictions. PSUs are included in total diluted shares of common stock outstanding when the performance measures have been deemed achieved but the PSUs have not yet been issued.  Fair value cost for stock options and warrants is calculated using the Black-Scholes valuation model and is expensed on a straight-line basis over the requisite service period of the grant. Compensation cost is reduced for forfeitures as they occur in accordance with ASU 2016-09 “Simplifying the Accounting for Share-Based Payments” (“ASU 2016-09”) .  At each subsequent reporting period prior to the lapse of restrictions on warrants, time-based restricted stock and PSUs granted to non-employees, the Company remeasures the aggregate compensation cost of such grants using the Company’s fair value at the end of such reporting period and revises the straight-line recognition of compensation cost in line with such remeasured amount. |
Leases | Leases  The Company leases certain properties for its offices and showrooms. Certain of the Company's lease agreements contain rent escalation clauses, free rent periods and tenant inducement payments. Rent expense for noncancelable operating leases with scheduled rent increases is recognized on a straight-line basis over the expected lease term. The difference between straight-line rent expense and the scheduled payment amounts is recorded as a deferred rent asset or liability.     |
Income Taxes | Income Taxes Current income taxes are based on the respective periods’ taxable income for federal, foreign and state income tax reporting purposes. Deferred tax liabilities and assets are determined based on the difference between the financial statement and income tax bases of assets and liabilities, using statutory tax rates in effect for the year in which the differences are expected to reverse. In accordance with ASU No. 2015-17 “Balance Sheet Classification of Deferred Taxes,” all deferred income taxes are reported and classified as non-current. A valuation allowance is required if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.  On December 22, 2017, the SEC staff issued Staff Accounting Bulletin (“SAB”) No. 118 which provides guidance on accounting for the tax effects of the Tax Cuts and Jobs Act ("TCJA"). The purpose of SAB No. 118 was to address any uncertainty or diversity of view in applying “ASC Topic 740”, Income Taxes in the reporting period in which the TCJA was enacted. SAB No. 118 addresses situations where the accounting is incomplete for certain income tax effects of the TJCA upon issuance of a company’s financial statements for the reporting period that includes the enactment date. SAB No. 118 allows for a provisional amount to be recorded if it is a reasonable estimate of the impact of the TCJA. Additionally, SAB No. 118 allows for a measurement period to finalize the impacts of the TCJA, not to extend beyond one year from the date of enactment. The Company’s accounting for certain elements of the TCJA was incomplete as of the period ended December 31, 2017. However, the Company was able to make reasonable estimates of the effects and, therefore, recorded provisional estimates for these items at December 31, 2017.  The Company applies the Financial Accounting Standards Board (“FASB”) guidance on accounting for uncertainty in income taxes. The guidance clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements in accordance with other authoritative GAAP and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The guidance also addresses derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Interest and penalties related to uncertain tax positions, if any, are recorded in income tax expense. Tax years that remain open for assessment for federal and state tax purposes include the years ended December 31, 2014 through December 31, 2017. |
Earnings Per Share | Earnings Per Share Basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) attributable to Sequential Brands Group, Inc. and Subsidiaries by the weighted-average number of common shares outstanding during the reporting period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the reporting period, including stock options, PSUs and warrants, using the treasury stock method, and convertible debt, using the if-converted method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive. The shares used to calculate basic and diluted EPS consist of the following:     Three Months Ended September 30, Nine Months Ended September 30,  2018 2017 2018 2017   Basic weighted-average common shares outstanding 63,911,481 62,998,944 63,578,121 62,796,716  Warrants - - - -  Stock options - - - -  Performance based restricted stock - - - -  Unvested restricted stock - - - -  Diluted weighted-average common shares outstanding 63,911,481 62,998,944 63,578,121 62,796,716   The computation of diluted EPS for the three and nine months ended September 30, 2018 and 2017 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:   Three Months Ended September 30, Nine Months Ended September 30,  2018 2017 2018 2017   Warrants - 801,760 - 801,760  Stock options - 84,000 - 84,000  Performance based restricted stock 31,162 - 49,202 -  Unvested restricted stock 328,353 972,355 995,568 972,355  Total 359,515 1,858,115 1,044,770 1,858,115   |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments which potentially expose the Company to credit risk consist primarily of cash, restricted cash and accounts receivable. Cash is held to meet working capital needs and future acquisitions. Restricted cash is pledged as collateral for a comparable amount of irrevocable standby letters of credit for certain of the Company’s leased properties. Substantially all of the Company’s cash and restricted cash are deposited with high quality financial institutions. At times, however, such cash and restricted cash may be in deposit accounts that exceed the Federal Deposit Insurance Corporation insurance limit. The Company has not experienced any losses in such accounts as of September 30, 2018 .  Concentration of credit risk with respect to accounts receivable is minimal due to the collection history. The Company performs periodic credit evaluations of its customers’ financial condition. The allowance for doubtful accounts is based upon the expected collectability of all accounts receivable. |
Customer Concentrations | Customer Concentrations The Company recorded net revenues of $4 0 . 8 million and $39.0 million during the three months ended September 30, 2018 and 2017 , respectively. During the three months ended September 30, 2018 , two licensees represented at least 10% of net revenue, accounting for 15% and 10% of the Company’s net revenue. During the three months ended September 30, 2017 , three licensees represented at least 10% of net revenue, accounting for 12% , 11% , and 10% of the Company’s net revenue.  The Company recorded net revenues of $121. 1 million and $120.6 million during the nine months ended September 30, 2018 and 2017, respectively. During the nine months ended September 30, 2018, two licensees represented at least 10% of net revenue, accounting for 13% and 10% of the Company’s net revenue. During the nine months ended September 30, 2017, three licensees represented at least 10% of net revenue, accounting for 11% , 11% , and 10% of the Company’s net revenue. |
Loss Contingencies | Loss Contingencies The Company recognizes contingent losses that are both probable and estimable. In this context, probable means circumstances under which events are likely to occur. The Company records legal costs pertaining to contingencies as incurred. |
Contingent Consideration | Contingent Consideration  The Company recognizes the acquisition-date fair value of contingent consideration as part of the consideration transferred in exchange for the acquiree or assets of the acquiree in a business combination. The contingent consideration is classified as either a liability or equity in accordance with ASC 480-10, Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity . If classified as a liability, the liability is remeasured to fair value at each subsequent reporting date until the contingency is settled. Increases in fair value are recorded as losses, while decreases are recorded as gains. If classified as equity, contingent consideration is not remeasured and subsequent settlement is accounted for within equity. |
Noncontrolling Interest |   Noncontrolling Interest  Noncontrolling interest recorded for the three and nine months ended September 30, 2018 represents income allocations to Elan Polo International, Inc., a member of DVS Footwear International, LLC, With You, Inc., a member of With You LLC (the partnership between the Company and Jessica Simpson) and JALP, LLC (“JALP”), a member of FUL IP Holdings, LLC (“FUL IP”). Noncontrolling interest recorded for the three and nine months ended September 30, 2017 represents income allocations to Elan Polo International, Inc., With You, Inc. and JALP. |
Reportable Segment | Reportable Segment An operating segment, in part, is a component of an enterprise whose operating results are regularly reviewed by the chief operating decision maker (the “CODM”) to make decisions about resources to be allocated to the segment and assess its performance. Operating segments may be aggregated only to a limited extent. The Company’s CODM, the Chief Executive Officer, reviews financial information presented on a consolidated basis, accompanied by disaggregated information about revenues for purposes of making operating decisions and assessing financial performance. Accordingly, the Company has determined that it has a single operating and reportable segment. In addition, the Company has no foreign office s or any assets i n foreign locations. The majority of the Company’s operations consist of a single revenue stream, which is the licensing of its trademark portfoli o, with additional revenues derived from television, book, café operations and certain commissions. |
Goodwill (Policy)
Goodwill (Policy) | 9 Months Ended |
Sep. 30, 2018 | |
Goodwill [Abstract] | |
Goodwill |  Goodwill represents the excess of the purchase price over the fair value of net assets acquired under the acquisition method of accounting. Goodwill is tested for impairment at the reporting unit level (operating segment or one level below an operating segment) on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. In evaluating goodwill for impairment, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Qualitative factors considered include, for example, macroeconomic and industry conditions, overall financial performance and other relevant entity-specific events. If the Company bypasses the qualitative assessment, or concludes that it is more likely than not that the fair value of a reporting unit is less than its carrying value, it then performs a goodwill impairment test to identify potential goodwill impairment and measure the amount of goodwill impairment to be recognized, if any.  The Company will compare the estimated fair value of the reporting unit with its carrying value. The Company has determined it has a single reporting unit. Fair value for the quantitative assessment is determined under an income approach using estimates of discounted future cash flows (the “Income Approach”). The Income Approach relies on assumptions such as the Company’s projected future earnings and appropriate discount rates.    Significant assumptions used in the Income Approach are as follows: (i) discount rates; (ii) projected annual revenue growth rates; and (iii) projected long-term growth rates. The Company’s estimates also factor in economic conditions and expectations of management which may change in the future based on period-specific facts and circumstances. The Company will corroborate the results of the Income Approach by reconciling to within a reasonable range of the Company’s market capitalization, (calculated as total common shares outstanding multiplied by the common equity price per share, as adjusted for a control premium factor). The control premium is estimated based upon control premiums observed in comparable market transactions.  If the estimated fair value of the reporting unit exceeds its carrying amount, no further analysis is needed. If, however, the estimated fair value of the reporting unit is less than its carrying amount, the Company will recognize an impairment change for the amount by which the carrying value exceeds the reporting unit’s fair value . |
Intangible Assets (Policy)
Intangible Assets (Policy) | 9 Months Ended |
Sep. 30, 2018 | |
Intangible Assets [Abstract] | |
Finite-lived Intangible Assets | Finite-lived intangible assets represent trademarks, customer agreements and patents related to the Company’s brands and a favorable lease. Finite-lived intangible assets are amortized on a straight-line basis over the estimated useful lives of the assets. The carrying value of finite-lived intangible assets and other long-lived assets is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are not amortized, but instead are subject to impairment evaluation. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Summary of Significant Accounting Policies [Abstract] | |
Shares Used to Calculate Basic And Diluted Earnings (Loss) Per Common Share | The shares used to calculate basic and diluted EPS consist of the following:     Three Months Ended September 30, Nine Months Ended September 30,  2018 2017 2018 2017   Basic weighted-average common shares outstanding 63,911,481 62,998,944 63,578,121 62,796,716  Warrants - - - -  Stock options - - - -  Performance based restricted stock - - - -  Unvested restricted stock - - - -  Diluted weighted-average common shares outstanding 63,911,481 62,998,944 63,578,121 62,796,716  |
Earnings Per Share, Basic and Diluted | The computation of diluted EPS for the three and nine months ended September 30, 2018 and 2017 excludes the common stock equivalents of the following potentially dilutive securities because their inclusion would be anti-dilutive:   Three Months Ended September 30, Nine Months Ended September 30,  2018 2017 2018 2017   Warrants - 801,760 - 801,760  Stock options - 84,000 - 84,000  Performance based restricted stock 31,162 - 49,202 -  Unvested restricted stock 328,353 972,355 995,568 972,355  Total 359,515 1,858,115 1,044,770 1,858,115  |
Fair Value Measurement of Fin_2
Fair Value Measurement of Financial Instruments (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Fair Value Measurement of Financial Instruments [Abstract] | |
Schedule of Indefinite-lived Assets | The following table shows the change in indefinite-lived intangible assets for the nine months ended September 30, 2018 (in thousands):     Balance at January 1, 2018 $ 995,170  Impairment of trademarks (17,899)  Sale of trademarks (11,473)  Amortization (648)  Additions 210  Balance at September 30, 2018 $ 965,360  |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | The following table sets forth the carrying value and the fair value of the Company’s financial assets and liabilities required to be disclosed at September 30, 2018 and December 31, 2017 :     Carrying Value Fair Value  Financial Instrument Level 9/30/2018 12/31/2017 9/30/2018 12/31/2017  (in thousands)  Interest rate caps 2 $ 542 $ 1,239 $ 542 $ 1,239  2016 Term Loans 2 $ 526,925 $ 551,913 $ 524,176 $ 542,655  2016 Revolving Loan 2 $ 115,000 $ 92,787 $ 114,837 $ 92,389  Legacy Payments 3 $ 2,479 $ 2,256 $ 2,479 $ 2,256  |
Schedule of Notional Amounts of Outstanding Derivative Positions | The components of the 2016 Cap Agreements as of September 30, 2018 are as follows:     Notional Value Derivative Asset Derivative Liability   (in thousands)   LIBOR based loans $ 500,000 $ 249 $ -  |
Revenues (Tables)
Revenues (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Revenues [Abstract] | |
Impact of Adoption of ASC 606 At Year End | Changes to the balances at January 1, 2018 resulting from the adoption of ASC 606 are as follows:     December 31, Impact of January 1,  2017 (As Reported) Adoption of ASC 606 2018  (in thousands)  Assets  Current Assets:  Accounts receivable, net $ 60,102 $ 6,335 $ 66,437  Liabilities  Current Liabilities:  Current portion of deferred revenue $ 8,102 $ 4,387 $ 12,489  Deferred income taxes 67,799 463 68,262  Equity  Accumulated deficit $ (225,369) $ 1,130 $ (224,239)  Noncontrolling interests 71,547 355 71,902  |
Impact of Adoption of ASC 606 On Statement of Operations | The impact to the benefit from income taxes for the three and n i ne months ended September 30, 2018 was a decrease of $0.2 million and $0.6 million , respectively, due to t he adoption of ASC 606 . The tables below summarize the impact of the adoption on the condensed consolidated statement s o f operations for the three and nine months ended September 30, 2018:    Three Months Ended September 30,  2018  (in thousands)  As Reported Adjustments due to ASC 606 Under previous guidance (ASC 605)   Net revenue $ 40,771 $ (464) $ 41,235  Operating expenses 23,515 - 23,515  Impairment charges 17,899 - 17,899  Loss from operations (643) (464) (179)  Other income (31) - (31)  Interest expense, net 15,635 - 15,635  Loss before income taxes (16,247) (464) (15,783)  Benefit from income taxes (8,213) (155) (8,058)  Net loss (8,034) (309) (7,725)  Net income attributable to noncontrolling interests (1,581) 4 (1,585)  Net loss attributable to Sequential Brands Group, Inc. and Subsidiaries $ (9,615) $ (305) $ (9,310)   Loss per share attributable to Sequential Brands Group, Inc. and Subsidiaries:  Basic and diluted $ (0.15) $ (0.00) $ (0.15)   Weighted-average common shares outstanding:  Basic and diluted 63,911,481 63,911,481 63,911,481    Nine Months Ended September 30,  2018  (in thousands)  As Reported Adjustments due to ASC 606 Under previous guidance (ASC 605)   Net revenue $ 121,082 $ (2,509) $ 123,591  Operating expenses 60,014 - 60,014  Impairment charges 17,899 - 17,899  Loss on sale of assets 7,117 - 7,117  Income from operations 36,052 (2,509) 38,561  Other income (135) - (135)  Interest expense, net 46,674 - 46,674  Loss before income taxes (10,487) (2,509) (7,978)  Benefit from income taxes (6,838) (577) (6,261)  Net loss (3,649) (1,932) (1,717)  Net income attributable to noncontrolling interests (4,643) 184 (4,827)  Net loss attributable to Sequential Brands Group, Inc. and Subsidiaries $ (8,292) $ (1,748) $ (6,544)   Loss per share attributable to Sequential Brands Group, Inc. and Subsidiaries:  Basic and diluted $ (0.13) $ (0.03) $ (0.10)   Weighted-average common shares outstanding:  Basic and diluted 63,578,121 63,578,121 63,578,121  |
Disaggregated Revenue | Disaggregated Revenue The following table presents revenue disaggregate d by source for the three and nine months ended September 30, 2018:     Three Months Ended September 30, Nine Months Ended September 30,  2018 2018  (in thousands)   Licensing Agreements $ 37,669 $ 112,995  Other 3,102 8,087  Total $ 40,771 $ 121,082  |
Contract Balances | The below table summarizes the net change in contract assets and contract liabilities from the date of adoption to September 30, 2018:    January 1, September 30,  2018 Changes 2018  (in thousands)   Contract assets $ 6,335 $ (2,303) $ 4,032  Contract liabilities 4,387 206 4,593  |
Future Performance Obligations | The below table summarizes amounts related to future performance obligations under fixed contractual arrangements as of September 30, 2018 and the periods in which they are expected to be earned and recognized as revenue:     Remainder of 2018 2019 2020 2021 2022 and Thereafter  Future Performance Obligations $ 22,418 $ 69,800 $ 54,261 $ 38,771 $ 55,835  |
Goodwill (Tables)
Goodwill (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Goodwill [Abstract] | |
Schedule of Goodwill | Previous changes in goodwill are summarized as follows (in thousands) :      Balance at January 1, 2017 $ 307,744  (Adjustment for) acquisition of Gaiam Brand Holdco, LLC (a) (3,621)  Impairment charges (304,123)  Balance at December 31, 2017 $ -  (a) Goodwill from the acquisition of Gaiam Brand Holdco, LLC represents the excess of the purchase price over the fair value of net assets acquired under the acquisition method of accounting.  |
Intangible Assets (Tables)
Intangible Assets (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Intangible Assets [Abstract] | |
Summary of Intangible Assets | Intangible assets are summarized as follows:     September 30, 2018 Useful Lives (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount   (in thousands)  Finite-lived intangible assets:  Trademarks 15 $ 5,474 $ (2,234) $ 3,240  Customer agreements 4 2,832 (2,562) 270  Favorable lease 2 537 (537) -  Patents 10 361 (318) 43  $ 9,204 $ (5,651) 3,553  Indefinite-lived intangible assets:  Trademarks 961,807   Intangible assets, net $ 965,360  \    December 31, 2017 Useful Lives (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount   (in thousands)  Finite-lived intangible assets:  Trademarks 15 $ 5,462 $ (1,913) $ 3,549  Customer agreements 4 2,832 (2,257) 575  Favorable lease 2 537 (537) -  Patents 10 665 (296) 369  $ 9,496 $ (5,003) 4,493  Indefinite-lived intangible assets:  Trademarks 990,677   Intangible assets, net $ 995,170  |
Summary of Future Annual Estimated Amortization Expense |  Estimated future annual amortization expense for intangible assets in service as of September 30, 2018 is summarized as follows:     Years ending December 31, (in thousands)  Remainder of 2018 $ 185  2019 627  2020 439  2021 436  2022 413  Thereafter 1,453  $ 3,553  |
Change in Indefinite-Lived Intangible Assets | The following table shows the change in indefinite-lived intangible assets for the nine months ended September 30, 2018 (in thousands):     Balance at January 1, 2018 $ 995,170  Impairment of trademarks (17,899)  Sale of trademarks (11,473)  Amortization (648)  Additions 210  Balance at September 30, 2018 $ 965,360  |
Long-Term Debt (Tables)
Long-Term Debt (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Long-Term Debt [Abstract] | |
Schedule of long term debt | The components of long-term debt are as follows:    September 30, December 31,  2018 2017   (in thousands)   2016 Term Loans $ 526,925 $ 551,913  2016 Revolving Loan 115,000 92,787  Unamortized deferred financing costs (25,399) (14,103)  Total long-term debt, net of unamortized deferred financing costs 616,526 630,597  Less: current portion of long-term debt 28,300 28,300  Long-term debt $ 588,226 $ 602,297  |
Stock-based Compensation (Table
Stock-based Compensation (Tables) | 9 Months Ended |
Sep. 30, 2018 | |
Stock-based Compensation [Abstract] | |
Summary of Stock Option Activity | The following table summarizes the Company’s stock option activity for the nine months ended September 30, 2018 :   Number of Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (in Years) Aggregate Intrinsic Value   (in thousands, except share and per share data)   Outstanding - January 1, 2018 84,001 $ 8.65 2.1 $ -  Granted - -  Exercised - -  Forfeited or canceled (26,500) (6.59)  Outstanding at September 30, 2018 57,501 $ 9.61 2.2 $ -   Exercisable - September 30, 2018 57,501 $ 9.61 2.2 $ -  |
Schedule of Warrants Activity and Nonvested Warrants | The following table summarizes the Company’s outstanding warrants for the nine months ended September 30, 2018 :   Number of Warrants Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life (in Years) Aggregate Intrinsic Value   (in thousands, except share and per share data)   Outstanding - January 1, 2018 770,160 $ 7.95 2.2 $ -  Granted - -  Exercised - -  Forfeited or canceled (560,160) (6.09)  Outstanding at September 30, 2018 210,000 $ 12.94 6.4 $ -   Exercisable - September 30, 2018 210,000 $ 12.94 6.4 $ -  |
Schedule of Restricted Stock Activity | A summary of the time-based restricted stock activity for the nine months ended September 30, 2018 is as follows:    Number of Shares Weighted-Average Grant Date Fair Value Weighted-Average Remaining Contractual Life (in Years)   (in thousands, except share and per share data)   Unvested - January 1, 2018 195,536 $ 7.23 1.8  Granted 235,296 1.70  Vested (118,612) (4.17)  Unvested - September 30, 2018 312,220 $ 4.23 1.2  |
Schedule of Restricted Stock Units Activity | A summary of the time-based restricted stock units activity for the nine months ended September 30, 2018 is as follows:    Number of Shares Weighted-Average Grant Date Fair Value Weighted-Average Remaining Contractual Life (in Years)   (in thousands, except share and per share data)   Unvested - January 1, 2018 736,400 $ 3.89 2.2  Granted 2,478,743 1.81  Vested (1,696,127) (2.17)  Forfeited or canceled (16,667) (7.61)  Unvested - September 30, 2018 1,502,349 $ 2.35 2.3  |
Schedule of Performance Stock Units Activity | A summary of the PSUs activity for the nine months ended September 30, 2018 is as follows:    Number of Shares Weighted-Average Grant Date Fair Value Weighted-Average Remaining Contractual Life (in Years)   (in thousands, except share and per share data)   Unvested - January 1, 2018 2,045,634 $ 5.83 2.0  Granted 785,000 1.98  Vested (350,408) (4.71)  Forfeited or canceled (255,697) (7.32)  Unvested - September 30, 2018 2,224,529 $ 4.48 1.0  |
Organization and Nature of Op_2
Organization and Nature of Operations (Details) | Sep. 30, 2018entity |
Minimum [Member] | |
Number of licensees | 135 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Narrative) (Details) | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
Sep. 30, 2018USD ($) | Sep. 30, 2017USD ($) | Sep. 30, 2018USD ($)segment | Sep. 30, 2017USD ($) | Dec. 31, 2017USD ($) | Jan. 01, 2018USD ($) | Jul. 01, 2016 | |
Significant Accounting Policies [Line Items] | |||||||
Advertising revenue | $ 1,200,000 | $ 800,000 | $ 1,600,000 | $ 800,000 | |||
Advertising expense | 600,000 | 0 | 800,000 | 0 | |||
Allowance for doubtful accounts receivable | 500,000 | 500,000 | $ 600,000 | ||||
Accounts receivable, net | 63,531,000 | 63,531,000 | 60,102,000 | $ 66,437,000 | |||
Impairment of trademarks | 17,899,000 | 36,505,000 | $ 17,899,000 | 36,505,000 | |||
Fair value assumption method used | Black-Scholes valuation model | ||||||
Net revenue | $ 40,771,000 | $ 39,025,000 | $ 121,082,000 | 120,569,000 | |||
Number of operating segments | segment | 1 | ||||||
Number of reportable segments | segment | 1 | ||||||
Proceeds from sale of available-for-sale securities | 5,757,000 | ||||||
Realized loss on sale of available-for-sale securities | $ 1,916,000 | ||||||
Goodwill, impairment loss | $ (304,123,000) | ||||||
Impairment of trademark | $ (7,117,000) | ||||||
Minimum [Member] | |||||||
Significant Accounting Policies [Line Items] | |||||||
Finite-lived intangible assets, useful lives | 2 years | ||||||
Maximum [Member] | |||||||
Significant Accounting Policies [Line Items] | |||||||
Finite-lived intangible assets, useful lives | 15 years | ||||||
Gaiam Pty Limited [Member] | |||||||
Significant Accounting Policies [Line Items] | |||||||
Equity method investment, noncontrolling interest | 49.90% | ||||||
Accounts Receivable [Member] | |||||||
Significant Accounting Policies [Line Items] | |||||||
Concentration risk, percentage | 43.00% | 53.00% | |||||
Accounts Receivable [Member] | License One [Member] | |||||||
Significant Accounting Policies [Line Items] | |||||||
Concentration risk, percentage | 21.00% | 25.00% | |||||
Accounts Receivable [Member] | License Two [Member] | |||||||
Significant Accounting Policies [Line Items] | |||||||
Concentration risk, percentage | 12.00% | 15.00% | |||||
Accounts Receivable [Member] | License Three [Member] | |||||||
Significant Accounting Policies [Line Items] | |||||||
Concentration risk, percentage | 10.00% | 13.00% | |||||
Sales Revenue, Net [Member] | License One [Member] | |||||||
Significant Accounting Policies [Line Items] | |||||||
Concentration risk, percentage | 15.00% | 12.00% | 13.00% | 11.00% | |||
Sales Revenue, Net [Member] | License Two [Member] | |||||||
Significant Accounting Policies [Line Items] | |||||||
Concentration risk, percentage | 10.00% | 11.00% | 10.00% | 11.00% | |||
Sales Revenue, Net [Member] | License Three [Member] | |||||||
Significant Accounting Policies [Line Items] | |||||||
Concentration risk, percentage | 10.00% | 10.00% |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies (Basic and Diluted Weighted Average Common Shares Outstanding) (Details) - shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Earnings Per Share [Abstract] | ||||
Basic weighted-average common shares outstanding | 63,911,481 | 62,998,944 | 63,578,121 | 62,796,716 |
Warrants | ||||
Stock options | ||||
Performance based restricted stock | ||||
Unvested restricted stock | ||||
Diluted weighted-average common shares outstanding | 63,911,481 | 62,998,944 | 63,578,121 | 62,796,716 |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies (Computation of Diluted EPS) (Details) - shares | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of earnings per share | 359,515 | 1,858,115 | 1,044,770 | 1,858,115 |
Warrants [Member] | ||||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of earnings per share | 801,760 | 801,760 | ||
Employee Stock Option [Member] | ||||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of earnings per share | 84,000 | 84,000 | ||
Performance based restricted stock | ||||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of earnings per share | 31,162 | 49,202 | ||
Restricted Stock | ||||
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||||
Antidilutive securities excluded from computation of earnings per share | 328,353 | 972,355 | 995,568 | 972,355 |
Fair Value Measurement of Fin_3
Fair Value Measurement of Financial Instruments (Narrative) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended | 21 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Dec. 31, 2016 | Sep. 30, 2018 | |
Impairment of trademarks | $ 17,899 | $ 36,505 | $ 17,899 | $ 36,505 | ||
Gross licensing revenue payable, percentage | 3.50% | |||||
Licensing revenue payment period | 5 years | |||||
Impairment of trademark | $ (7,117) | |||||
Interest Rate Cap [Member] | ||||||
Derivative, notional amount | 500,000 | $ 500,000 | $ 500,000 | $ 500,000 | ||
Derivative, cap interest rate | 1.50% | |||||
Derivative, maturity date | Nov. 23, 2018 | Nov. 23, 2018 | ||||
Interest Expense [Member] | ||||||
Accretion expense | $ 100 | $ 100 | $ 200 |
Fair Value Measurement of Fin_4
Fair Value Measurement of Financial Instruments (Schedule of Indefinite-lived Assets) (Details) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended |
Sep. 30, 2018 | Dec. 31, 2017 | |
Indefinite-lived Intangible Assets [Line Items] | ||
Balance at January 1 | $ 990,677 | $ 1,025,260 |
Additions | 199 | (461) |
Impairment charges | (17,899) | (36,505) |
Sale of trademarks | (11,170) | |
Reclassified to finite-lived intangible assets | 2,383 | |
Balance at period end | 961,807 | 990,677 |
Trademarks [Member] | ||
Indefinite-lived Intangible Assets [Line Items] | ||
Balance at January 1 | 990,677 | |
Balance at period end | $ 961,807 | $ 990,677 |
Fair Value Measurement of Fin_5
Fair Value Measurement of Financial Instruments (Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Legacy Payments | $ 2,479 | $ 2,256 |
Reported Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Legacy Payments | 2,479 | 2,256 |
Interest Rate Cap [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative liability | 542 | 1,239 |
Interest Rate Cap [Member] | Reported Value Measurement [Member] | Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative liability | 542 | 1,239 |
BoA Term Loans [Member] | Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Nonrecurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt instrument, fair value disclosure | 524,176 | 542,655 |
BoA Term Loans [Member] | Reported Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Nonrecurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt instrument, fair value disclosure | 526,925 | 551,913 |
Revolving Loans [Member] | Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Nonrecurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt instrument, fair value disclosure | 114,837 | 92,389 |
Revolving Loans [Member] | Reported Value Measurement [Member] | Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Nonrecurring [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Debt instrument, fair value disclosure | $ 115,000 | $ 92,787 |
Fair Value Measurement of Fin_6
Fair Value Measurement of Financial Instruments (Schedule of Notional Amounts of Outstanding Derivative Positions) (Details) - Interest Rate Cap [Member] - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2016 |
Derivatives, Fair Value [Line Items] | ||
Notional Value | $ 500,000 | $ 500,000 |
Derivative Asset | 249 | |
Derivative Liability |
Revenues (Narrative) (Details)
Revenues (Narrative) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Jan. 01, 2018 | Dec. 31, 2017 | |
Retained Earnings (Accumulated Deficit), Total | $ (232,531) | $ (232,531) | $ (224,239) | $ (225,369) | ||
Accounts receivable, net | 63,531 | 63,531 | 66,437 | 60,102 | ||
Current portion of deferred revenue | 11,143 | 11,143 | 12,489 | 8,102 | ||
Noncontrolling interests | 71,220 | 71,220 | 71,902 | 71,547 | ||
Deferred tax liability | 61,417 | 61,417 | $ 68,262 | 67,799 | ||
Net revenue | 40,771 | $ 39,025 | 121,082 | $ 120,569 | ||
Benefit from income taxes | (8,213) | $ (3,842) | (6,838) | $ (142) | ||
Difference between Revenue Guidance in Effect before and after Topic 606 [Member] | ||||||
Retained Earnings (Accumulated Deficit), Total | 1,130 | |||||
Accounts receivable, net | 6,335 | |||||
Current portion of deferred revenue | 4,387 | |||||
Noncontrolling interests | 355 | |||||
Deferred tax liability | $ 463 | |||||
Net revenue | (464) | (2,509) | ||||
Benefit from income taxes | $ (155) | $ (577) |
Revenues (Changes to Balances f
Revenues (Changes to Balances from Adoption) (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Jan. 01, 2018 | Dec. 31, 2017 |
Accounts receivable, net | $ 63,531 | $ 66,437 | $ 60,102 |
Current portion of deferred revenue | 11,143 | 12,489 | 8,102 |
Deferred tax liability | 61,417 | 68,262 | 67,799 |
Accumulated deficit | (232,531) | (224,239) | (225,369) |
Noncontrolling interests | $ 71,220 | $ 71,902 | 71,547 |
Difference between Revenue Guidance in Effect before and after Topic 606 [Member] | |||
Accounts receivable, net | 6,335 | ||
Current portion of deferred revenue | 4,387 | ||
Deferred tax liability | 463 | ||
Accumulated deficit | 1,130 | ||
Noncontrolling interests | $ 355 |
Revenues (Impact of Adoption of
Revenues (Impact of Adoption of ASC 606) (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Net revenue | $ 40,771 | $ 39,025 | $ 121,082 | $ 120,569 |
Operating expenses | 23,515 | 16,071 | 60,014 | 57,379 |
Impairment charges | 17,899 | 36,505 | 17,899 | 36,505 |
Loss on sale of assets | 7,117 | |||
(Loss) income from operations | (643) | (13,551) | 36,052 | 26,685 |
Other (income) expense | (31) | (214) | (135) | 1,553 |
Interest expense, net | 15,635 | 15,237 | 46,674 | 44,600 |
Loss before income taxes | (16,247) | (28,574) | (10,487) | (19,468) |
Benefit from income taxes | (8,213) | (3,842) | (6,838) | (142) |
Net loss | (8,034) | (24,732) | (3,649) | (19,326) |
Net (income) loss attributable to noncontrolling interests | (1,581) | 552 | (4,643) | (3,504) |
Net loss attributable to Sequential Brands Group, Inc. and Subsidiaries | $ (9,615) | $ (24,180) | $ (8,292) | $ (22,830) |
Loss per share attributable to Sequential Brands Group, Inc. and Subsidiaries: | ||||
Basic and diluted (in dollars per share) | $ (0.15) | $ (0.38) | $ (0.13) | $ (0.36) |
Weighted-average common shares outstanding: | ||||
Basic (in shares) | 63,911,481 | 62,998,944 | 63,578,121 | 62,796,716 |
Diluted (in shares) | 63,911,481 | 62,998,944 | 63,578,121 | 62,796,716 |
Difference between Revenue Guidance in Effect before and after Topic 606 [Member] | ||||
Net revenue | $ (464) | $ (2,509) | ||
(Loss) income from operations | (464) | (2,509) | ||
Loss before income taxes | (464) | (2,509) | ||
Benefit from income taxes | (155) | (577) | ||
Net loss | (309) | (1,932) | ||
Net (income) loss attributable to noncontrolling interests | 4 | 184 | ||
Net loss attributable to Sequential Brands Group, Inc. and Subsidiaries | $ (305) | $ (1,748) | ||
Loss per share attributable to Sequential Brands Group, Inc. and Subsidiaries: | ||||
Basic and diluted (in dollars per share) | $ 0 | $ (0.03) | ||
Weighted-average common shares outstanding: | ||||
Basic (in shares) | 63,911,481 | 63,578,121 | ||
Calculated under Revenue Guidance in Effect before Topic 606 [Member] | ||||
Net revenue | $ 41,235 | $ 123,591 | ||
Operating expenses | 23,515 | 60,014 | ||
Impairment charges | 17,899 | 17,899 | ||
Loss on sale of assets | 7,117 | |||
(Loss) income from operations | (179) | 38,561 | ||
Other (income) expense | (31) | (135) | ||
Interest expense, net | 15,635 | 46,674 | ||
Loss before income taxes | (15,783) | (7,978) | ||
Benefit from income taxes | (8,058) | (6,261) | ||
Net loss | (7,725) | (1,717) | ||
Net (income) loss attributable to noncontrolling interests | (1,585) | (4,827) | ||
Net loss attributable to Sequential Brands Group, Inc. and Subsidiaries | $ (9,310) | $ (6,544) | ||
Loss per share attributable to Sequential Brands Group, Inc. and Subsidiaries: | ||||
Basic and diluted (in dollars per share) | $ (0.15) | $ (0.10) | ||
Weighted-average common shares outstanding: | ||||
Basic (in shares) | 63,911,481 | 63,578,121 |
Revenues (Disaggregated Revenue
Revenues (Disaggregated Revenue) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended |
Sep. 30, 2018 | Sep. 30, 2018 | |
Disaggregated revenue | $ 40,771 | $ 121,082 |
Licensing Agreements [Member] | ||
Disaggregated revenue | 37,669 | 112,995 |
Other Contract [Member] | ||
Disaggregated revenue | $ 3,102 | $ 8,087 |
Revenues (Contract Balances) (D
Revenues (Contract Balances) (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Contract assets | $ 4,032 | $ 6,335 |
Contract liabilities | 4,593 | $ 4,387 |
Difference between Revenue Guidance in Effect before and after Topic 606 [Member] | ||
Contract assets | (2,303) | |
Contract liabilities | $ 206 |
Revenues (Future Performance Ob
Revenues (Future Performance Obligations) (Details) $ in Thousands | Sep. 30, 2018USD ($) |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2018-10-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Future Performance Obligations | $ 22,418 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Future Performance Obligations | 69,800 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Future Performance Obligations | 54,261 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Future Performance Obligations | 38,771 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Future Performance Obligations | $ 55,835 |
Revenues (Future Performance _2
Revenues (Future Performance Obligations Alternate) (Details) | 9 Months Ended |
Sep. 30, 2018 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2018-10-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 3 months |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 1 year |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period | 0 years |
Goodwill (Summary of Goodwill)
Goodwill (Summary of Goodwill) (Details) $ in Thousands | 12 Months Ended |
Dec. 31, 2017USD ($) | |
Schedule Of Goodwill [Line Items] | |
Beginning Balance | $ 307,744 |
Goodwill, impairment loss | (304,123) |
Ending Balance | |
Acquisition of Gaiam, Inc. Branded Consumer Business [Member] | |
Schedule Of Goodwill [Line Items] | |
(Adjustment for) acquisition | $ (3,621) |
Intangible Assets (Narrative) (
Intangible Assets (Narrative) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2018 | Jun. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Amortization expense | $ 200 | $ 200 | $ 600 | $ 700 | |
Loss on asset held for sale | (7,117) | ||||
Impairment charges | $ 17,899 | $ 36,505 | 17,899 | $ 36,505 | |
Revo Trademark [Member] | |||||
Loss on asset held for sale | $ (7,100) | ||||
FUL [Member] | |||||
Loss on asset held for sale | $ (2,000) |
Intangible Assets (Summary of I
Intangible Assets (Summary of Intangible Assets) (Details) - USD ($) $ in Thousands | 9 Months Ended | 12 Months Ended | |
Sep. 30, 2018 | Dec. 31, 2017 | Dec. 31, 2016 | |
Schedule Of Finite Lived Intangible Assets [Line Items] | |||
Gross Carrying Amount | $ 9,204 | $ 9,496 | |
Accumulated Amortization | (5,651) | (5,003) | |
Intangible assets amortization, total | 3,553 | 4,493 | |
Indefinite lived intangible assets | 961,807 | 990,677 | $ 1,025,260 |
Net Carrying Amount, Intangible Assets | 965,360 | 995,170 | |
Trademarks [Member] | |||
Schedule Of Finite Lived Intangible Assets [Line Items] | |||
Indefinite lived intangible assets | $ 961,807 | $ 990,677 | |
Trademarks [Member] | |||
Schedule Of Finite Lived Intangible Assets [Line Items] | |||
Useful Lives | 15 years | 15 years | |
Gross Carrying Amount | $ 5,474 | $ 5,462 | |
Accumulated Amortization | (2,234) | (1,913) | |
Intangible assets amortization, total | $ 3,240 | $ 3,549 | |
Customer Contracts [Member] | |||
Schedule Of Finite Lived Intangible Assets [Line Items] | |||
Useful Lives | 4 years | 4 years | |
Gross Carrying Amount | $ 2,832 | $ 2,832 | |
Accumulated Amortization | (2,562) | (2,257) | |
Intangible assets amortization, total | $ 270 | $ 575 | |
Favorable Lease [Member] | |||
Schedule Of Finite Lived Intangible Assets [Line Items] | |||
Useful Lives | 2 years | 2 years | |
Gross Carrying Amount | $ 537 | $ 537 | |
Accumulated Amortization | $ (537) | $ (537) | |
Patents [Member] | |||
Schedule Of Finite Lived Intangible Assets [Line Items] | |||
Useful Lives | 10 years | 10 years | |
Gross Carrying Amount | $ 361 | $ 665 | |
Accumulated Amortization | (318) | (296) | |
Intangible assets amortization, total | $ 43 | $ 369 |
Intangible Assets (Future Annua
Intangible Assets (Future Annual Estimated Amortization Expense) (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 |
Intangible Assets [Abstract] | ||
Remainder of 2018 | $ 185 | |
2,019 | 627 | |
2,020 | 439 | |
2,021 | 436 | |
2,022 | 413 | |
Thereafter | 1,453 | |
Intangible assets amortization, total | 3,553 | $ 4,493 |
Net Carrying Amount, Intangible Assets | $ 965,360 | $ 995,170 |
Intangible Assets (Changes in I
Intangible Assets (Changes in Indefinite-Lived Intangible Assets) (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Dec. 31, 2017 | |
Balance at January 1 | $ 990,677 | $ 1,025,260 | $ 1,025,260 | ||
Finite-Lived Intangible Assets, Net | $ 3,553 | 3,553 | 4,493 | ||
Impairment of trademarks | (17,899) | $ (36,505) | (17,899) | (36,505) | |
Sale of trademarks | 11,170 | ||||
Amortization Of Intangible Assets | 200 | $ 200 | 600 | $ 700 | |
Additions | 199 | (461) | |||
Balance at period end | 961,807 | 961,807 | 990,677 | ||
Indefinite-lived Intangible Assets [Member] | |||||
Balance at January 1 | 995,170 | ||||
Impairment of trademarks | (17,899) | ||||
Sale of trademarks | (11,473) | ||||
Amortization Of Intangible Assets | (648) | ||||
Additions | 210 | ||||
Balance at period end | $ 965,360 | $ 965,360 | $ 995,170 |
Long-Term Debt (Narrative) (Det
Long-Term Debt (Narrative) (Details) - USD ($) | Aug. 07, 2018 | Jul. 02, 2016 | Sep. 30, 2018 | Dec. 31, 2016 | Dec. 31, 2017 | Jul. 01, 2016 |
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt Issuance Costs, Noncurrent | $ 14,600,000 | |||||
Deferred financing costs | 100,000 | |||||
Proceeds from issuance of long-term debt | 107,607,000 | |||||
Long-term debt | $ 616,526,000 | $ 630,597,000 | ||||
Debt instrument orderly liquidation value of registered trademarks percentage benchmark | 10.00% | |||||
Interest Rate Cap [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Derivative, notional amount | $ 500,000,000 | $ 500,000,000 | ||||
Derivative, cap interest rate | 1.50% | |||||
Derivative, maturity date | Nov. 23, 2018 | Nov. 23, 2018 | ||||
Revolving Credit Facility [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Line of credit facility, maximum borrowing capacity | $ 110,000,000 | |||||
Line of credit facility, unused capacity, commitment fee percentage | 0.375% | |||||
BoA Credit Agreement [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument period of credit agreement | 5 years | 5 years | ||||
Proceeds from issuance of long-term debt | $ 335,000,000 | $ 287,500,000 | ||||
Long-term debt | 258,000,000 | |||||
Debt instrument covenant payment percentage of intellectual property disposed liquidation value | 50.00% | 50.00% | ||||
Debt instrument covenant payment percentage of net proceeds related to other assets constituting collateral | 100.00% | 100.00% | ||||
Debt instrument orderly liquidation value of registered trademarks percentage benchmark | 15.00% | |||||
Debt instrument, covenant description | (i) maintain a positive net income (as defined in the agreement), (ii) satisfy a maximum loan to value ratio set at 50.0% (applicable to the Revolving Loans and Tranche A Loans) and (iii) satisfy a maximum consolidated first lien leverage ratio, initially set at 2.80:1.00, decreasing over the term of the Amended BoA Credit Agreement until reaching the final maximum ratio of 2.50:1.00 for the fiscal quarter ended September 30, 2018 and thereafter. | |||||
Debt instrument, description | (i) the loans outstanding under the Amended BoA Credit Agreement plus, (a) where intellectual property is disposed, 50.0% of the disposed intellectual property's orderly liquidation value, and (b) where any other assets constituting collateral are disposed or upon the receipt of certain insurance proceeds, 100% of the net proceeds thereof, subject to certain reinvestment rights; and (ii) the Tranche A-1 Loans to the extent that the outstanding principal amount thereof exceeds 10.0% of the orderly liquidation value of the registered trademarks owned by the BoA Facility Loan Parties. | |||||
BoA Term Loans [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Long-term debt | $ 526,925,000 | 551,913,000 | ||||
Debt instrument, periodic payment | $ 5,000,000 | |||||
Debt instrument, date of first required payment | Sep. 30, 2016 | |||||
Tranche A [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Maximum loan to value ratio | 50.00% | |||||
Tranche A [Member] | Notes Payable to Banks [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, face amount | 133,000,000 | |||||
Long-term debt | 133,000,000 | |||||
Tranche A [Member] | Notes Payable to Banks [Member] | London Interbank Offered Rate (LIBOR) [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 3.50% | |||||
Tranche A [Member] | Notes Payable to Banks [Member] | Base Rate [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 2.50% | |||||
Tranche A [Member] | Revolving Credit Facility [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Consolidated first lien leverage ratio | 2.80% | |||||
Line of credit facility, covenant terms | (i) the Revolving Credit Facility and Tranche A Loans, as would not have caused the consolidated first lien leverage ratio, determined on a pro forma basis after giving effect to any such increase, to exceed 2.33:1.00 and (ii) the Tranche A-1 Loans, as would not have caused the consolidated first lien leverage ratio, determined on a pro forma basis after giving effect to any such increase, to exceed (a) with respect to any increase, the proceeds of which will be used solely to finance an acquisition, 2.50:1.00 and (b) with respect to any other increase, 2.40:1.00, subject to the satisfaction of certain conditions in the Amended BoA Credit Agreement. | |||||
Tranche A -1 Term Loans [Member] | Scenario Plan Two [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Consolidated first lien leverage ratio | 2.50% | |||||
Tranche A -1 Term Loans [Member] | Scenario Plan Three [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Consolidated first lien leverage ratio | 2.40% | |||||
Tranche A -1 Term Loans [Member] | London Interbank Offered Rate (LIBOR) [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 7.00% | |||||
Tranche A -1 Term Loans [Member] | Base Rate [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 6.00% | |||||
Tranche A -1 Term Loans [Member] | Notes Payable to Banks [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, face amount | 44,500,000 | |||||
Long-term debt | 44,500,000 | |||||
Revolving Loans [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Long-term debt | $ 115,000,000 | $ 92,787,000 | 80,500,000 | |||
Maximum loan to value ratio | 50.00% | |||||
Revolving Loans [Member] | Notes Payable to Banks [Member] | London Interbank Offered Rate (LIBOR) [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 3.50% | |||||
Revolving Loans [Member] | Notes Payable to Banks [Member] | Base Rate [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 2.50% | |||||
GSO Credit Agreement [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument covenant payment percentage of intellectual property disposed liquidation value | 50.00% | 50.00% | ||||
Debt instrument covenant payment percentage of net proceeds related to other assets constituting collateral | 100.00% | 100.00% | ||||
Debt instrument, date of first required payment | Mar. 31, 2017 | |||||
Consolidated first lien leverage ratio | 2.80% | |||||
Debt instrument, covenant description | (a) in the event the consolidated total leverage ratio was at least 4.00:1.00, 75% thereof, (b) in the event the consolidated total leverage ratio was less than 4.00:1.00 but at least 3.00:1.00, 50% thereof and (c) in the event the consolidated total leverage ratio was less than 3.00:1.00, 0% thereof. On March 31, 2017, the loans under the Amended FS/KKR Credit Agreement commenced amortization in quarterly installments, equal to 2.00% per annum of the original aggregate principal amount thereof. | |||||
Debt instrument consolidated total leverage ratio | 7.25% | |||||
Amortization percentage for quarterly installments of the original aggregate principal amount | 2.00% | |||||
Line of credit facility, interest rate description | (i) the LIBOR rate plus an applicable margin of 8.25% or 9.00% per annum or (ii) the base rate plus an applicable margin of 7.25% or 8.00% per annum, in each case based upon the consolidated total leverage ratio. | |||||
Debt instrument, covenant compliance | At September 30, 2018, the Company is in compliance with the covenants included in the New Amended FS/KKR Credit Agreement. | |||||
Debt instrument, debt default, description of violation or event of default | The Amended FS/KKR Credit Agreement contained certain customary events of default, including a change of control. If an event of default occurs and was not cured within any applicable grace period or was not waived, the FS/KKR Agent, at the request of the lenders under the Amended FS/KKR Credit Agreement, was required to take various actions, including, without limitation, the acceleration of amounts due thereunder. | |||||
GSO Credit Agreement [Member] | Scenario, Plan [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Final consolidated first lien leverate ratio | 2.50% | |||||
Debt instrument consolidated total leverage ratio | 6.50% | |||||
GSO Credit Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 8.25% | |||||
GSO Credit Agreement [Member] | Base Rate [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 7.25% | |||||
GSO Credit Agreement [Member] | Additional Loan Facility [Member] | Scenario, Plan [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument consolidated total leverage ratio | 6.00% | |||||
GSO Credit Agreement Reinvestment Rights Scenario One [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument covenant payment percentage of net proceeds related to other assets constituting collateral | 75.00% | 75.00% | ||||
GSO Credit Agreement Reinvestment Rights Scenario Two [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument covenant payment percentage of net proceeds related to other assets constituting collateral | 50.00% | 50.00% | ||||
GSO Credit Agreement Reinvestment Rights Scenario Three [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument covenant payment percentage of net proceeds related to other assets constituting collateral | 0.00% | 0.00% | ||||
Amended KKR Credit Agreement [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, face amount | $ 415,000,000 | |||||
Amended KKR Credit Agreement [Member] | Scenario Plan One [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument consolidated total leverage ratio | 6.00% | |||||
Third Amended BoA Credit Agreement [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Long-term debt | $ 335,000,000 | |||||
Debt instrument, periodic payment | 5,000,000 | |||||
Third Amended BoA Tranche A Loans | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, face amount | 150,000,000 | |||||
Long-term debt | 150,000,000 | |||||
Third Amended BoA Tranche A-1 Loans [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Long-term debt | $ 70,000,000 | |||||
Third Amended BoA Tranche A-1 Loans [Member] | London Interbank Offered Rate (LIBOR) [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 7.00% | |||||
Third Amended BoA Tranche A-1 Loans [Member] | Base Rate [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 6.00% | |||||
Amended BoA Revolving Credit Commitments [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, face amount | $ 130,000,000 | |||||
Consolidated first lien leverage ratio | 3.875% | |||||
Final consolidated first lien leverate ratio | 2.875% | |||||
Long-term Line of Credit | $ 115,000,000 | |||||
Line of Credit Facility, Commitment Fee Percentage | 0.375% | |||||
Amended BoA Revolving Loans and Amended Tranche A Loans | London Interbank Offered Rate (LIBOR) [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 3.50% | |||||
Amended BoA Revolving Loans and Amended Tranche A Loans | Base Rate [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 2.50% | |||||
FS/KKR Credit Agreement | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, face amount | $ 314,000,000 | |||||
Debt instrument, periodic payment | $ 2,100,000 | |||||
Debt instrument, covenant description | (i) a maximum consolidated total leverage ratio, initially set at 7.25:1.00, decreasing over the term of the New Amended FS/KKR Credit Agreement until reaching a final maximum ratio of 6.25:1.00 for the fiscal quarter ending September 30, 2022 and thereafter and (ii) a maximum consolidated first lien leverage ratio, initially set at 3.875:1.00, decreasing over the term of the New Amended FS/KKR Credit Agreement until reaching a final maximum ratio of 2.875:1.00 for the fiscal quarter ending September 30, 2022 and thereafter. | |||||
FS/KKR Credit Agreement | Scenario Plan One [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument consolidated total leverage ratio | 6.00% | |||||
FS/KKR Credit Agreement | London Interbank Offered Rate (LIBOR) [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 8.75% | |||||
FS/KKR Credit Agreement | Base Rate [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 7.75% | |||||
Maximum [Member] | Revolving Credit Facility [Member] | Scenario Plan One [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Consolidated first lien leverage ratio | 2.33% | |||||
Maximum [Member] | BoA Credit Agreement [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Consolidated first lien leverage ratio | 2.80% | |||||
Maximum [Member] | Tranche A [Member] | Scenario Plan One [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Consolidated first lien leverage ratio | 2.33% | |||||
Maximum [Member] | GSO Credit Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, interest rate, stated percentage | 9.00% | |||||
Maximum [Member] | GSO Credit Agreement [Member] | Base Rate [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, interest rate, stated percentage | 8.00% | |||||
Maximum [Member] | GSO Credit Agreement Reinvestment Rights Scenario One [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument consolidated total leverage ratio | 4.00% | |||||
Maximum [Member] | GSO Credit Agreement Reinvestment Rights Scenario Two [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument consolidated total leverage ratio | 4.00% | |||||
Maximum [Member] | GSO Credit Agreement Reinvestment Rights Scenario Three [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument consolidated total leverage ratio | 3.00% | 3.00% | ||||
Minimum [Member] | BoA Credit Agreement [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Final consolidated first lien leverate ratio | 2.50% | |||||
Minimum [Member] | GSO Credit Agreement Reinvestment Rights Scenario One [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument consolidated total leverage ratio | 4.00% | 4.00% | ||||
Minimum [Member] | GSO Credit Agreement Reinvestment Rights Scenario Two [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument consolidated total leverage ratio | 3.00% | 3.00% | ||||
Minimum [Member] | Third Amended BoA Credit Agreement [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Maximum loan to value ratio | 42.50% | |||||
Minimum [Member] | Third Amended BoA Tranche A-1 Loans [Member] | London Interbank Offered Rate (LIBOR) [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 6.00% | |||||
Minimum [Member] | Third Amended BoA Tranche A-1 Loans [Member] | Base Rate [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 5.00% | |||||
Minimum [Member] | Amended BoA Revolving Loans and Amended Tranche A Loans | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Maximum loan to value ratio | 50.00% | |||||
Minimum [Member] | Amended BoA Revolving Loans and Amended Tranche A Loans | London Interbank Offered Rate (LIBOR) [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 3.00% | |||||
Minimum [Member] | Amended BoA Revolving Loans and Amended Tranche A Loans | Base Rate [Member] | ||||||
Disclosure Long Term Debt Additional Information [Line Items] | ||||||
Debt instrument, basis spread on variable rate | 2.00% |
Long-Term Debt (Schedule of Lon
Long-Term Debt (Schedule of Long Term Debt) (Details) - USD ($) $ in Thousands | Sep. 30, 2018 | Dec. 31, 2017 | Jul. 01, 2016 |
Unamortized deferred financing costs | $ (25,399) | $ (14,103) | |
Total long-term debt, net of unamortized deferred financing costs | 616,526 | 630,597 | |
Less: current portion of long-term debt | 28,300 | 28,300 | |
Long term debt, noncurrent | 588,226 | 602,297 | |
BoA Credit Agreement [Member] | |||
Total long-term debt, net of unamortized deferred financing costs | $ 258,000 | ||
BoA Term Loans [Member] | |||
Total long-term debt, net of unamortized deferred financing costs | 526,925 | 551,913 | |
Revolving Loans [Member] | |||
Total long-term debt, net of unamortized deferred financing costs | $ 115,000 | $ 92,787 | $ 80,500 |
Stock-based Compensation (Narra
Stock-based Compensation (Narrative) (Details) - USD ($) | Feb. 20, 2018 | Feb. 28, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Dec. 31, 2017 |
Performance based restricted stock | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 200,000 | $ 900,000 | $ 3,500,000 | ||||
Granted | 785,000 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 1.98 | ||||||
Unvested shares | 2,224,529 | 2,224,529 | 2,045,634 | ||||
Performance based restricted stock | Chief Executive Officer [Member] | Share-based Compensation Award, Tranche One [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 0 | $ 3,000,000 | $ 0 | 3,000,000 | |||
Share-based compensation arrangement by share-based payment award, award vesting period | 3 years | ||||||
Restricted shares granted | 300,000 | ||||||
Grant date fair value of stock units granted | $ 800,000 | ||||||
Performance based restricted stock | Chief Executive Officer [Member] | Share-based Compensation Award, Tranche Two [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | 100,000 | $ 200,000 | |||||
Share-based compensation arrangement by share-based payment award, award vesting period | 3 years | ||||||
Restricted shares granted | 175,000 | ||||||
Grant date fair value of stock units granted | $ 700,000 | ||||||
Performance based restricted stock | Chief Executive Officer [Member] | Share-based Compensation Award, Tranche Three [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Granted | 36,000 | ||||||
Performance based restricted stock | Former Chief Executive Officer [Member] | Share-based Compensation Award, Tranche One [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Accelerated shares, vesting | 200,000 | ||||||
Accelerated shares, compensation expense | $ 2,900,000 | ||||||
Performance based restricted stock | Former Chief Executive Officer [Member] | Share-based Compensation Award, Tranche Three [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Granted | 60,000 | ||||||
Performance based restricted stock | Employees and Consultants [Member] | Share-based Compensation Award, Tranche One [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | 500,000 | ||||||
Granted | 208,883 | ||||||
Performance based restricted stock | Employees and Consultants [Member] | Share-based Compensation Award, Tranche Two [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 3,000,000 | 3,000,000 | |||||
Share-based compensation arrangement by share-based payment award, award vesting period | 3 years | ||||||
Restricted shares granted | 41,600 | ||||||
Grant date fair value of stock units granted | $ 100,000 | ||||||
Performance based restricted stock | Employees and Consultants [Member] | Share-based Compensation Award, Tranche Three [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | 600,000 | ||||||
Granted | 164,978 | ||||||
Performance based restricted stock | Employees [Member] | Share-based Compensation Award, Tranche One [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 200,000 | ||||||
Restricted shares granted | 135,000 | ||||||
Grant date fair value of stock units granted | $ 300,000 | ||||||
Performance based restricted stock | Employee [Member] | Share-based Compensation Award, Tranche One [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 0 | ||||||
Restricted shares granted | 83,250 | ||||||
Performance based restricted stock | Employee [Member] | Share-based Compensation Award, Tranche Two [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Share-based compensation arrangement by share-based payment award, award vesting period | 3 years | ||||||
Restricted shares granted | 200,000 | ||||||
Grant date fair value of stock units granted | $ 400,000 | ||||||
Performance based restricted stock | Employee [Member] | Share-based Compensation Award, Tranche Three [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 0 | ||||||
Granted | 200,000 | ||||||
Share-based compensation arrangement by share-based payment award, award vesting period | 2 years | ||||||
Grant date fair value of stock units granted | $ 500,000 | ||||||
Performance based restricted stock | Employee [Member] | Share-based Compensation Award, Tranche Four [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 3,000,000 | 3,000,000 | |||||
Share-based compensation arrangement by share-based payment award, award vesting period | 3 years | ||||||
Restricted shares granted | 200,000 | ||||||
Grant date fair value of stock units granted | $ 700,000 | ||||||
Performance based restricted stock | Consultant [Member] | Share-based Compensation Award, Tranche One [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 0 | ||||||
Share-based compensation arrangement by share-based payment award, award vesting period | 5 years | ||||||
Restricted shares granted | 250,000 | ||||||
Grant date fair value of stock units granted | $ 500,000 | ||||||
Restricted Stock | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 100,000 | 100,000 | 400,000 | 500,000 | |||
Unrecognized compensation expense, other than options | $ 300,000 | $ 300,000 | |||||
Unrecognized compensation expense, period for recognition | 1 year 2 months 12 days | ||||||
Granted | 235,296 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 1.70 | ||||||
Unvested shares | 312,220 | 312,220 | 195,536 | ||||
Restricted Stock | Board of Directors [Member] | Share-based Compensation Award, Tranche One [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Stock granted, value, share-based compensation, gross | $ 100,000 | $ 200,000 | |||||
Share-based compensation arrangement by share-based payment award, award vesting period | 1 year | ||||||
Restricted shares granted | 235,296 | ||||||
Grant date fair value of stock units granted | $ 400,000 | ||||||
Restricted Stock | Board of Directors [Member] | Share-based Compensation Award, Tranche Two [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | 100,000 | $ 200,000 | |||||
Share-based compensation arrangement by share-based payment award, award vesting period | 1 year | ||||||
Restricted shares granted | 111,112 | ||||||
Grant date fair value of stock units granted | $ 400,000 | ||||||
Restricted Stock Units (RSUs) [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | 1,100,000 | $ 200,000 | 2,200,000 | $ 1,400,000 | |||
Unrecognized compensation expense, other than options | $ 2,700,000 | $ 2,700,000 | |||||
Unrecognized compensation expense, period for recognition | 2 years 3 months 18 days | ||||||
Granted | 2,478,743 | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ 1.81 | ||||||
Unvested shares | 1,502,349 | 1,502,349 | 736,400 | ||||
Restricted Stock Units (RSUs) [Member] | Chief Executive Officer [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 100,000 | ||||||
Share-based compensation arrangement by share-based payment award, award vesting period | 3 years | ||||||
Restricted shares granted | 100,000 | ||||||
Grant date fair value of stock units granted | $ 400,000 | ||||||
Restricted Stock Units (RSUs) [Member] | Former Chief Executive Officer [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Accelerated shares, vesting | 66,667 | ||||||
Accelerated shares, compensation expense | $ 700,000 | ||||||
Restricted Stock Units (RSUs) [Member] | Former Chief Financial Officer [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Granted | 60,000 | ||||||
Stock granted, value, share-based compensation, gross | $ 300,000 | ||||||
Share-based compensation arrangement by share-based payment award, award vesting period | 2 years | ||||||
Restricted Stock Units (RSUs) [Member] | Employees and Consultants [Member] | Share-based Compensation Award, Tranche One [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 800,000 | $ 1,500,000 | |||||
Granted | 325,000 | 1,635,257 | |||||
Grant date fair value of stock units granted | $ 700,000 | $ 3,000,000 | |||||
Restricted Stock Units (RSUs) [Member] | Employees and Consultants [Member] | Share-based Compensation Award, Tranche Two [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | 100,000 | $ 300,000 | $ 100,000 | ||||
Share-based compensation arrangement by share-based payment award, award vesting period | 3 years | ||||||
Grant date fair value of stock units granted | $ 1,400,000 | ||||||
Restricted Stock Units (RSUs) [Member] | Employees [Member] | Share-based Compensation Award, Tranche Two [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Granted | 843,486 | ||||||
Restricted Stock Units (RSUs) [Member] | Employees [Member] | Share-based Compensation Award, Tranche Three [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Granted | 200,000 | 276,753 | |||||
Employee Stock Option [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | 0 | $ 0 | |||||
Unrecognized compensation expense, options | $ 0 | $ 0 | |||||
Nonvested options | 0 | 0 | |||||
Minimum [Member] | Performance based restricted stock | Employees [Member] | Share-based Compensation Award, Tranche One [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Share-based compensation arrangement by share-based payment award, award vesting period | 1 year | ||||||
Minimum [Member] | Restricted Stock Units (RSUs) [Member] | Employees and Consultants [Member] | Share-based Compensation Award, Tranche One [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Share-based compensation arrangement by share-based payment award, award vesting period | 5 years | ||||||
Maximum [Member] | Performance based restricted stock | Chief Executive Officer [Member] | Share-based Compensation Award, Tranche Two [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 100,000 | ||||||
Maximum [Member] | Performance based restricted stock | Employees [Member] | Share-based Compensation Award, Tranche One [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Share-based compensation arrangement by share-based payment award, award vesting period | 2 years | ||||||
Maximum [Member] | Restricted Stock | Board of Directors [Member] | Share-based Compensation Award, Tranche Two [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 100,000 | ||||||
Maximum [Member] | Restricted Stock Units (RSUs) [Member] | Chief Executive Officer [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | 100,000 | $ 100,000 | $ 100,000 | ||||
Maximum [Member] | Restricted Stock Units (RSUs) [Member] | Employees and Consultants [Member] | Share-based Compensation Award, Tranche Two [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | 100,000 | ||||||
Maximum [Member] | Employee Stock Option [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | 100,000 | 100,000 | |||||
Warrants [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | 0 | $ 0 | |||||
Unrecognized compensation expense, other than options | $ 0 | $ 0 | |||||
Unvested shares | 0 | 0 | |||||
Warrants [Member] | Maximum [Member] | |||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
Allocated share-based compensation expense | $ 100,000 | $ 100,000 |
Stock-based Compensation (Summa
Stock-based Compensation (Summary of Stock Option Activity) (Details) - USD ($) | 9 Months Ended | 12 Months Ended |
Sep. 30, 2018 | Dec. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ||
Weighted Average Remaining Contractual Life (in years) | 2 years 1 month 6 days | |
Employee Stock Option [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ||
Outstanding beginning, Number of Options | 84,001 | |
Forfeited or Canceled, Number of Options | (26,500) | |
Outstanding ending, Number of Options | 57,501 | 84,001 |
Exercisable, Number of Options | 57,501 | |
Outstanding beginning, Weighted Average Exercise Price | $ 8.65 | |
Forfeited or Canceled, Weighted Average Exercise Price | (6.59) | |
Outstanding ending, Weighted Average Exercise Price | 9.61 | $ 8.65 |
Exercisable, Weighted Average Exercise Price | $ 9.61 | |
Weighted Average Remaining Contractual Life (in years) | 2 years 2 months 12 days | |
Exercisable, Weighted Average Remaining Contractual Life (in years) | 2 years 2 months 12 days | |
Outstanding, Aggregate Intrinsic Value | ||
Exercisable, Aggregate Intrinsic Value |
Stock-based Compensation (Sched
Stock-based Compensation (Schedule of Warrant Activity) (Details) - USD ($) | 9 Months Ended | 12 Months Ended |
Sep. 30, 2018 | Dec. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ||
Weighted Average Remaining Contractual Life (in years) | 2 years 1 month 6 days | |
Warrants [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ||
Outstanding beginning, Number of Options | 770,160 | |
Forfeited or Canceled, Number of Options | (560,160) | |
Outstanding ending, Number of Options | 210,000 | 770,160 |
Exercisable, Number of Options | 210,000 | |
Outstanding beginning, Weighted Average Exercise Price | $ 7.95 | |
Forfeited or Canceled, Weighted Average Exercise Price | (6.09) | |
Outstanding ending, Weighted Average Exercise Price | 12.94 | $ 7.95 |
Exercisable, Weighted Average Exercise Price | $ 12.94 | |
Weighted Average Remaining Contractual Life (in years) | 6 years 4 months 24 days | 2 years 2 months 12 days |
Exercisable, Weighted Average Remaining Contractual Life (in years) | 6 years 4 months 24 days | |
Outstanding, Aggregate Intrinsic Value | ||
Exercisable, Aggregate Intrinsic Value |
Stock-based Compensation (Sum_2
Stock-based Compensation (Summary of Restricted Stock Activity) (Details) - Restricted Stock - $ / shares | 9 Months Ended | 12 Months Ended |
Sep. 30, 2018 | Dec. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Unvested, beginning of period | 195,536 | |
Granted | 235,296 | |
Vested | (118,612) | |
Unvested, end of period | 312,220 | 195,536 |
Outstanding, Weighted Average Exercise Price | $ 7.23 | |
Granted, Weighted-Average Grant Date Fair Value | 1.70 | |
Vested, Weighted Average Grant Date Fair Value | (4.17) | |
Outstanding, Weighted Average Exercise Price | $ 4.23 | $ 7.23 |
Weighted-Average Contractual Life (Years) | 1 year 2 months 12 days | 1 year 9 months 18 days |
Stock-based Compensation (Sum_3
Stock-based Compensation (Summary of Restricted Stock Unit Activity) (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares | 9 Months Ended | 12 Months Ended |
Sep. 30, 2018 | Dec. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Unvested, beginning of period | 736,400 | |
Granted | 2,478,743 | |
Vested | (1,696,127) | |
Forfeited or canceled | 16,667 | |
Unvested, end of period | 1,502,349 | 736,400 |
Outstanding, Weighted Average Exercise Price | $ 3.89 | |
Granted, Weighted-Average Grant Date Fair Value | 1.81 | |
Vested, Weighted Average Grant Date Fair Value | (2.17) | |
Forfeited or canceled, Weighted-Average Grant Date Fair Value | (7.61) | |
Outstanding, Weighted Average Exercise Price | $ 2.35 | $ 3.89 |
Weighted-Average Contractual Life (Years) | 2 years 3 months 18 days | 2 years 2 months 12 days |
Stock-based Compensation (Sum_4
Stock-based Compensation (Summary of Performance Stock Unit Activity) (Details) - Performance based restricted stock - $ / shares | 9 Months Ended | 12 Months Ended |
Sep. 30, 2018 | Dec. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Unvested, beginning of period | 2,045,634 | |
Granted | 785,000 | |
Vested | (350,408) | |
Forfeited or canceled | (255,697) | |
Unvested, end of period | 2,224,529 | 2,045,634 |
Outstanding, Weighted Average Exercise Price | $ 5.83 | |
Granted, Weighted-Average Grant Date Fair Value | 1.98 | |
Vested, Weighted Average Grant Date Fair Value | (4.71) | |
Forfeited or canceled, Weighted-Average Grant Date Fair Value | (7.32) | |
Outstanding, Weighted Average Exercise Price | $ 4.48 | $ 5.83 |
Weighted-Average Contractual Life (Years) | 1 year | 2 years |
Related Party Transactions (Nar
Related Party Transactions (Narrative) (Details) - USD ($) | Dec. 04, 2015 | Nov. 17, 2014 | Jan. 01, 2013 | Sep. 30, 2015 | Jul. 31, 2013 | Sep. 30, 2018 | Jun. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Dec. 31, 2016 | Dec. 31, 2017 | Aug. 15, 2014 |
Related Party Transaction [Line Items] | |||||||||||||
Operating expenses | $ 23,515,000 | $ 16,071,000 | $ 60,014,000 | $ 57,379,000 | |||||||||
Loss on asset held for sale | $ (7,117,000) | ||||||||||||
Proceeds from sale of available-for-sale securities | 5,757,000 | ||||||||||||
FUL [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Business combination, recognized identifiable assets acquired and liabilities assumed, intangible assets, other than goodwill | $ 8,900,000 | ||||||||||||
Business acquisition, percentage of voting interests acquired | 50.50% | ||||||||||||
Payments to acquire businesses, net of cash acquired | $ 4,500,000 | ||||||||||||
Restricted Stock | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Other than options, granted | 235,296 | ||||||||||||
Performance based restricted stock | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Other than options, granted | 785,000 | ||||||||||||
FUL [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Loss on asset held for sale | $ (2,000,000) | ||||||||||||
Tengram Capital Partners Limited Partnership [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Percentage of beneficially owned outstanding common stock | 5.00% | ||||||||||||
Payments for services | 200,000 | $ 700,000 | 500,000 | ||||||||||
Accounts payable, related parties, current | 0 | 0 | $ 0 | ||||||||||
Payments to acquire available-for-sale securities | $ 12,000,000 | ||||||||||||
Proceeds from sale of available-for-sale securities | 5,800,000 | ||||||||||||
License agreement annual payment | $ 900,000 | ||||||||||||
FUL IP [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Income (loss) attributable to noncontrolling interest | 0 | (2,400,000) | (700,000) | (2,400,000) | |||||||||
ES Originals Inc [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Royalty revenue | 1,100,000 | 3,500,000 | 3,800,000 | 11,300,000 | |||||||||
Due from related parties, current | 4,900,000 | 4,900,000 | 7,200,000 | ||||||||||
Sales commission revenue | 1,900,000 | 2,800,000 | |||||||||||
Accounts receivable | 1,000,000 | 1,000,000 | |||||||||||
Expenses, related party | 200,000 | ||||||||||||
ES Originals Inc [Member] | Other Assets [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Sales commission revenue | 1,300,000 | ||||||||||||
TCP Employee [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Operating expenses | 100,000 | 100,000 | $ 200,000 | 200,000 | |||||||||
TCP Employee [Member] | Restricted Stock | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Other than options, granted | 125,000 | ||||||||||||
Share-based compensation arrangement by share-based payment award, award vesting period | 4 years | ||||||||||||
TCP Employee [Member] | Performance based restricted stock | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Other than options, granted | 180,000 | 200,000 | |||||||||||
Share-based compensation arrangement by share-based payment award, award vesting period | 3 years | ||||||||||||
TCP Employee [Member] | Share-based Compensation Award, Tranche One [Member] | Performance based restricted stock | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Share based compensation, vesting percentage | 20.00% | 33.30% | |||||||||||
TCP Employee [Member] | Share-based Compensation Award, Tranche Two [Member] | Performance based restricted stock | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Share based compensation, vesting percentage | 20.00% | 33.30% | |||||||||||
TCP Employee [Member] | Share-based Compensation Award, Tranche Three [Member] | Performance based restricted stock | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Share based compensation, vesting percentage | 60.00% | 33.40% | |||||||||||
TCP Employee [Member] | Share-based Compensation Award, Consulting Arrangment, Tranche One [Member] | Restricted Stock | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Other than options, granted | 150,000 | ||||||||||||
TCP Employee [Member] | Share-based Compensation Award, Consulting Arrangment, Tranche Two [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Other than options, granted | 300,000 | ||||||||||||
IP License Agreement and Intangible Asset Agreement [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Terms of agreement, description | for calendar years 2018 through 2020 exceed $195 million or the gross licensing revenues for calendar year 2020 equal or exceed $65 million. | ||||||||||||
Aggregate gross revenues per agreement, benchmark | $ 195,000,000 | ||||||||||||
Gross revenues per agreement, benchmark | $ 65,000,000 | ||||||||||||
Intangible asset agreement annual payment | 1,700,000 | $ 1,700,000 | |||||||||||
License agreement payments during period | 100,000 | 300,000 | 1,400,000 | ||||||||||
Accretion expense | $ 100,000 | 200,000 | 300,000 | 500,000 | |||||||||
Compensation arrangement with individual, shares issued | 300,000 | ||||||||||||
Compensation arrangement with individual, fair value of shares issued | $ 600,000 | ||||||||||||
Compensation arrangement with individual, compensation expense | 600,000 | ||||||||||||
IP License Agreement [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Expenses, related party | 1,000,000 | $ 1,000,000 | |||||||||||
License agreement payments during period | 300,000 | 300,000 | |||||||||||
License agreement annual payment | 1,300,000 | 1,300,000 | |||||||||||
Due to related parties, current | 5,800,000 | 5,800,000 | 6,400,000 | ||||||||||
IP License Agreement [Member] | Other Noncurrent Liabilities [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Due to related parties, current | 2,900,000 | 2,900,000 | 3,600,000 | ||||||||||
IP License Agreement [Member] | Accounts Payable and Accrued Liabilities [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Due to related parties, current | 2,900,000 | 2,900,000 | 2,800,000 | ||||||||||
Tommie Copper, Incorporated [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Royalty revenue | 3,100,000 | ||||||||||||
Due from related parties, current | 1,000,000 | 1,000,000 | |||||||||||
Due from related parties, noncurent | 2,100,000 | $ 2,100,000 | |||||||||||
TCP Agreement [Member] | TCP Employee [Member] | Share-based Compensation Award, Consulting Arrangment, Tranche One [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Share-based compensation arrangement by share-based payment award, award vesting period | 3 years | ||||||||||||
TCP Agreement [Member] | TCP Employee [Member] | Share-based Compensation Award, Consulting Arrangment, Tranche Two [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Share-based compensation arrangement by share-based payment award, award vesting period | 3 years | ||||||||||||
Share based compensation, vesting percentage | 25.00% | ||||||||||||
Maximum [Member] | ES Originals Inc [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Expenses, related party | 100,000 | ||||||||||||
Maximum [Member] | TCP Employee [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Due to related parties, current | 100,000 | $ 100,000 | $ 100,000 | ||||||||||
Maximum [Member] | IP License Agreement and Intangible Asset Agreement [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
License agreement payments during period | $ 800,000 | ||||||||||||
Maximum [Member] | Tommie Copper, Incorporated [Member] | |||||||||||||
Related Party Transaction [Line Items] | |||||||||||||
Royalty revenue | $ 100,000 |